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Multiple Sclerosis (MS) is a chronic, degenerative neurological condition. It is
associated with a range of disabling physical, emotional, cognitive, and social sequelae.
It has been demonstrated that people with MS are impaired relative to healthy controls at
recognising emotion from facial expression and prosody. It has also been demonstrated
that other neurological populations are impaired at recognising the emotional states of
others. The present study aimed to further explore the relationship between MS and
emotion recognition from facial expression and ascertain whether impaired recognition of
emotion from facial expression was associated with reports of everyday social
functioning.
(2) Method
Thirty people with MS were assessed using the Facial Expression of Emotion: Stimuli
and Tests, comprised of the Ekman 60 Faces and the Emotion Hexagon. Their
performance was compared to the published normative data of the FEEST collected from
neurologically healthy controls (n = 227; n = 125 respectively). Each MS participant was
asked to complete a questionnaire about everyday functional behaviour, the Brock
Adaptive Functioning Questionnaire. A parallel version was completed for each MS




The MS group were significantly worse at overall recognition of emotion (p<.001;
p<0.05). Using published cut-off scores, 36.67% of the MS group were classified as
impaired on the Ekman 60 Faces; 23.33% on the Emotion Hexagon, significantly greater
than the than the 5% expected from the normative data (/?<.001). There were also
significant between-group differences on recognition of individual emotions.
BAFQ
BAFQ informant reports of aggression were significantly correlated with recognition of
disgust on both FEEST tests (p = .001). Although several other correlations were
approaching significance, no other significant correlations (i.e. /?<.01) were found.
Scores on the BAFQ were generally low, suggesting few social behaviour impairments in
the current sample.
(4) Discussion
It was confirmed that people with MS have difficulty recognising emotion from facial
expression but insufficient evidence was found to show that this was related to reported
social behaviour. The implications for further research are discussed, along with a
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The Central Nervous System (CNS) is the centre of all communication within the body.
Information from the outside world is processed, stored, and used to initiate instructions
for bodily behaviour. Comprising the brain and spine, the CNS is composed of two cell
types: neurons (nerve cells) and glial cells (support cells). The neurons are responsible
for transporting communications in the form of electrical impulses throughout the CNS.
The communication enters at the neuron's dendrites, travels through the cell body, along
the length of the axon and terminates at the synapses. At the synapses the message is
passed to the dendrites of another neuron and the communication continues to move
through the CNS.
The glial cells have several functions including the provision of the fatty material,
myelin, which surrounds the neuronal axons. Myelin serves to insulate the axon to help
the electrical impulses to travel with speed and accuracy. In this sense it is much like the
plastic coating which surrounds electrical cables. Damage to the myelin sheath, as occurs
in Multiple Sclerosis (MS), can significantly impair the function of the neurons and as
such the efficient operation of the CNS.
1.1 Multiple Sclerosis
MS is a chronic and lifelong neurological disease. The name is derived from the
condition's defining characteristic; the multiple areas of scar-like lesions - or scleroses -
spread throughout the CNS which develop following demyelination. The location of the
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sclerotic plaques within the CNS determines the presenting symptoms which can include
motor dysfunction, impaired bowel and bladder function, cognitive changes, visual
disorders, and problems with speech. The range and severity of presenting problems is
highly idiosyncratic, with considerable variation between individuals diagnosed with the
condition. However, Confavreux and Vukusic (2006) argue that the course ofMS can be
described by two clinical phenomenon: "relapses of acute neurological symptoms, which
end with a partial or complete remission, and progression, which refers to the steady and
irreversible worsening of symptoms and signs over 6 months." (pg. 606).
1.1.1 MS Sub-types
MS can be broadly divided into four sub-categories according to the experience of
relapse and progression.
Benign MS
In benign MS episodes of relapse are infrequent and the level of disability caused is mild.
Recovery from a relapse is complete, with no residual symptoms between episodes.
Benign MS is often only diagnosed posthumously when post-mortem examination
reveals scarring throughout the CNS (NICE Guidelines, 2003).
Relapsing/Remitting MS
Approximately 80% of people who are diagnosed with MS experience episodes of
relapse and remission. Typically, in relapsing/remitting MS symptoms subside
completely during a period of remission and functioning returns to the pre-morbid
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baseline level. However, over time, a remission may not lead to complete recovery and
residual symptoms may persist (NICE Guidelines, 2003).
Secondary Progressive MS
Secondary progressive MS initially presents as relapsing/remitting MS, where episodes
of relapse are followed by complete remission. However, as time progresses symptom
severity gradually increases independent of discrete episodes of relapse. Disability
caused by the disease becomes more acute and permanent. (NICE Guidelines, 2003).
All secondary progressive patients begin with the relapsing/remitting sub-type but 5-15
years after onset symptoms worsen (Coyle, 2000).
Primary Progressive MS
In primary progressive MS there are no episodes of relapse per se. Rather, there is a
gradual increase in symptom severity over time. The level of disability may occasionally
(and temporarily) plateau, but otherwise there is a persistent worsening of the condition.
Approximately 10-15% of people diagnosed with MS have primary progressive MS from
onset (NICE Guidelines, 2003).
1.1.2 Prevalence and Incidence
Multiple Sclerosis (MS) is the most common non-traumatic neurological disorder in
young adults (Montreuil and Petropoulou, 2003). In the UK prevalence figures vary
widely; Compston (1995) reported that prevalence per 100,000 ranges from 99 to 178
according to a cross section of studies conducted within different areas of the UK. This
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variance was also reflected by NICE (2003), which stated that in the UK at any one time
there are 100-120 people per 100,000 with an MS diagnosis and 3-7 people per 100,000
are newly diagnosed with MS every year.
Prevalence rates within Scotland are generally higher than within the rest of the UK (e.g.
Sutherland, 1956; Shepherd and Downie, 1978; Downie, 1984). Rothwell and Charlton
(1998) reported prevalence rates per 100,000 of 203 in Lothian and 219 in the Borders
region. Incidence rates per 100,000 were 12.2 and 10.1 for Lothian and the Borders
respectively.
It is common for people who have MS to require frequent contact from health care
providers. Murphy et al (1998) calculated the economic consequence of MS within
several European countries, including the UK. They reported that the approximate cost
(reported in US dollars) for three months of care in the UK ranges from $5,125 to
$14,622, (£2,493 to £7,114 at the present exchange rate) depending on the stage of the
disease and level of disability. They concluded that "MS represents a major financial
burden on the individual, the family, health services and society, and these costs increase
with time."
1.1.3 Risk Factors
Prevalence and incidence studies have investigated potential risk factors which may
increase an individual's susceptibility to the disease, particularly the role of
environmental and genetic risk factors.
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World-wide prevalence data show that MS occurs more frequently within certain
countries and continents. Several theories have been put forward to explain this finding.
Many authors have drawn attention to the host country's latitudinal location (e.g. Miller
et al, 1990), the latitudinal gradient hypothesis.
Closer examination of specific populations within high-risk countries demonstrated racial
variance with regard MS risk. Specifically, it appears that peoples indigenous to high-
risk countries have lower rates of prevalence (e.g. Maoris in New Zealand, Skegg et al,
1987; North American Indians in Canada, Hader et al, 1985). These studies argue that
the primary risk factor for MS is therefore genetic and that the observed variance of
world-wide prevalence is attributable to the migration of high-risk populations.
Recent prevalence data collected in Scotland endorse the genetic-vulnerability
hypothesis. Rothwell and Charlton (1998) note the absence of a latitudinal gradient
affecting prevalence within either England and Wales or Scotland. They explain the
increased prevalence within Scotland as a consequence of an increased genetic
susceptibility within the Scottish population.
1.1.4 Pathophysiology and Neuroanatomy
Pathophysiology
In MS it is widely understood that the process of demyelination responsible for
presenting neurological symptoms occurs due to the activity of the immune system.
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Typically, there is a barrier which protects the brain from the potentially harmful
neurotoxic effects of the blood, the blood-brain barrier (BBB). In MS the BBB is thought
to be faulty and certain immune system cells, T-cells are able to enter the CNS. T-cells
react to healthy parts of the CNS as though they were viruses. The action of the T-cells
triggers further immunological responses, such as inflammation and activation of
additional immune system cells. Ultimately, this process results in axonal demyelination
and the faulty operation of the neurones.
The remission of the clinical symptoms of MS which typically follow episodes of relapse
may well be the result of remyelination. This is the repair of damaged myelin sheaths
which enables neurons to perform normally once again. However, the repaired myelin is
often incomplete and less effective than the original. Furthermore, repeated damage
limits the effectiveness of subsequent neuronal repair. During later stages of MS,
damage to the axons becomes permanent, as do associated clinical symptoms.
Neuroanatomy ofMS
Although the sclerotic lesions are spread apparently at random throughout the entirety of
the CNS, it has been reported that certain regions of the brain are more prone than others.
The majority of lesions are to be found within the white matter surrounding the
ventricles. The ventricles are cavities within the brain which are filled with cerebro¬
spinal fluid (CSF). Periventricular lesions are typically found in the body and atrium of
the lateral ventricles. They have also been observed in the anterior, inferior and posterior
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horns of the lateral ventricle, the floor of the fourth ventricle and surrounding the third
ventricle (Ormerod et al, 1987; Brownell and Hughes, 1962).
The corpus callosum, the bundle of fibres which connects the two cerebral hemispheres,
is in close proximity to the lateral ventricles and is another common site for lesions to
appear (Simon et al, 1986; Gean-Marton et al, 1991). It is thought that lesions spread
from the neighbouring ventricles to the inner callosum via the ependymal veins.
The fourth ventricle projects posteriorly, down through the brainstem which is adjacent
to, and shares reciprocal connections with, the cerebellum. Lesions are often found
located within both of these areas, especially in established MS (Brainin et al, 1987). It
is also common for lesions to be found upon the optic nerve which is part of the visual
pathway and connects the retina to the lateral geniculate body (e.g. Ebers, 1986).
1.1.5 Diagnosis
The diagnosis of MS can be complex and protracted. This is partly because there is no
single test for the disease, but also because the symptoms could potentially be explained
by a variety of other neurological conditions. Noseworthy et al, (2000) list a range of
metabolic disorders, autoimmune diseases, infections, and vascular disorders which have
symptoms in common with MS.
Given these complications, NICE (2003) recommend that a diagnosis of MS should only
be given once there is clear evidence of lesions occupying different areas of the CNS and
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occurring on different occasions; in other words, lesions distributed through space and
time. Consequently they recommend that, following a first episode of unexplained
neurological problems, MS should be considered but no diagnosis given at that stage.
However, following the second presentation of these problems, additional investigations
should be conducted by a Consultant Neurologist.
NICE (2003) recommend that a diagnosis should be made based on the outcome of a
combination of tests rather than on one alone. Neurologists therefore make use of
various investigative tools to help inform their decision making. Magnetic Resonance
Imaging (MRI) scans identify old and active lesions in the CNS, and show any damage
sustained by the BBB. Evoked potential studies test the speed of neuronal transmission
between, for example, the eye and the visual cortex. Scarring of the neural pathway
slows the speed of communication between neurones and such latencies would be
highlighted by the investigation. A lumbar puncture can be performed in order to extract
a sample of cerebro-spinal fluid (CSF). The sample is investigated for elevated white-
blood cell count and presence of oligoclonal bands which would provide evidence that
cells of the auto-immune system had crossed the BBB (Coyle, 2000).
1.2 Presenting Problems in Multiple Sclerosis
People who have MS can present with a wide variety of symptoms which can change and
develop as the disease progresses. This is a consequence of the widespread location of
the sclerotic plaques throughout the CNS. As reported, individual patterns of
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neurological symptoms can be highly idiosyncratic. These symptoms can be broadly
categorised as physical or psychological.
1.2.1 Physical Symptoms
Physical symptoms are closely associated with lesion activity within the brain stem and
cerebellum (Rudick, 1992). They are often the most noticeable consequence of MS
because of the tangible affect on mobility, vision, and limb strength and their consequent
impact on the persons' ability to perform everyday tasks. Perhaps because of this, it is
the presence of unexplained physical changes which initially motivates many individuals
to seek referral for neurological investigation in first or second episode MS. Physical
impairment is commonly measured in MS using the expanded disability status scale
(EDSS, Kurtzke, 1983). This is a brief and repeatable rating system focusing largely
upon deficits within various domains of physical symptomatology; a high score on the
EDSS is related to increased physical impairment.
The range of physical impairments caused by MS is potentially vast; however, three of
the most common symptoms are listed below:
Motor symptoms
Motor symptoms are an almost universal consequence of MS with between 80 and 90%
of people reporting persistent or remitting difficulties with ambulation, spasticity, altered
sensation, or limb weakness, amongst others (Lezak, 2004).
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Optic neuritis
As reported above, lesions are commonly found occupying the optic nerve. Optic
neuritis presents when the efficiency of transmission of the optic nerve becomes
compromised, either by demyelination or neuronal inflammation or degeneration, which
can than cause a range of symptoms including partial or total loss of vision, blurred
vision, double vision, and impaired eye movement (e.g. Frohman, Zimmerman and
Frohman, 2000). The consequences of optic neuritis are often temporary. MS is not the
sole cause of optic neuritis (alternative underlying pathologies include viral-bacterial
infections, autoimmune disorders, and vasculitis) but it is its most common cause
(Lechtenberg, 1988).
Fatigue
Many individuals diagnosed with MS report extreme fatigue which causes profound
disability. In a study examining fatigue in MS, more than half of the sample surveyed
reported that fatigue was amongst their most disabling symptoms (Fisk et al, 1994).
People who have MS can perceive fatigue as affecting cognitive, occupational and social
activity (Schwartz, Coulthard-Morris and Zeng, 1996).
1.2.2 Psychological Consequences
1.2.2.1 Affective Disorders
Affective disorders are a common presenting complaint in MS. Indeed, Diaz-Olavarrieta
et al (1999) reported that neuropsychiatric symptoms were present in 95% of their MS
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sample, compared with just 16% of their control group. These findings are particularly
striking given that they excluded patients with a pre-morbid history of major psychiatric
illness and those experiencing an acute relapse. Furthermore, there are reports to suggest
that affective disorders can be the primary clinical manifestations of MS (Skegg, 1993;
Asghar-Ali et al, 2004).
Depression
Depression has received considerable attention from researchers investigating mood
disorder and MS. It is widely reported to be a common feature of the disease and is
understood by some to be amongst its defining symptoms (Mohr and Cox, 2001). The
lifetime prevalence rate ofMajor Depressive Disorder (MDD) in MS is high, with reports
between 25.7% (Patten et al, 2003) and 50% (e.g. Sadovnick et al, 1991). Minden et al
(1987) report that in their sample of MS patients (n = 50), 14% reported one episode of
MDD prior to onset ofMS symptoms whereas after onset the prevalence had increased to
54%.
One problem with diagnosing depression co-morbid with MS is that many of the
behavioural and physical symptoms associated with depression are also common physical
symptoms of MS itself, e.g. fatigue, disturbed sleep and impaired concentration. The
diagnosis of depression in MS requires detailed assessment to ensure that it does not go
untreated. Also, if depression is perceived to be a natural reaction to living with an acute,
degenerative and life-long neurological disorder then access to psychiatric and
psychotherapeutic treatment may not be considered appropriate or even necessary
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(Feinstein, 2002). Sollom and Kneebone (2007) observed that although prevalence of
major depression was high within their sample (n = 495), few sought treatment.
Diagnostic issues, clinical assumptions, and individual beliefs regarding the provision of
treatment may in part explain the high prevalence of suicidal ideation within the MS
population. Feinstein (2002) reported that approximately one third of people with MS
have suicidal thoughts over their lifetime. This is significantly higher than the prevalence
rates reported for the general population (between 2.3% and 14.6% in western societies,
Casey et al, 2006). Perhaps unsurprisingly therefore there are higher rates of completed
suicide within the MS population; Sadovnick et al (1991), investigating mortality and
MS, reported that of a sample of 3,126, suicide accounted for 15% of all deaths, over
seven times greater than the general, age matched population.
Anxiety
Compared with depression, anxiety in MS has received relatively little attention from
researchers. Information about prevalence is therefore more limited and considered to
contain methodological flaws (Mohr and Cox, 2001). However, Feinstein et al (1999),
reported that 25% of their sample (n = 152) had clinically significant anxiety, either in
isolation or co-morbid with depression. Galeazzi et al (2005) reported a lifetime
prevalence of 36% for anxiety. To put these figures in context, in the general population,
there is a lifetime prevalence of 3-8% for diagnosed Generalised Anxiety Disorder (DSM
IV, 1994).
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The profound affect that mood disorders can have on an MS population was also
highlighted by Feinstein et al (1999). They reported that increased anxiety co-morbid
with depression was associated with greater risk of suicidal ideation, somatic complaints
and social dysfunction. Furthermore, in a disease where medication is often via self-
administered injection, specific phobic disorders such as fear of needles can have a
significant impact on treatment adherence (Mohr, Boudewyn et al, 2001; Mohr, Cox and
Merluzzi, 2005).
As with depression, anxiety in MS can often be considered to be a natural consequence of
the diagnosis and its inherent uncertainty. Hence clinically significant anxiety can
proceed untreated which increases the risk of suicidal ideation and self-harm (Korostil
and Feinstein, 2007).
Euphoria and Pathological Laughing and Crying (PLC)
Euphoria refers to a persistent state of optimism in spite of apparently contradictory
circumstances. It has been associated with MS since the time of the earliest
investigations into the disease. However, it is now considered to affect no more than
10% of those who have long-standing MS with significant neurological impairment
(Kesselring and Klement, 2001).
Pathological laughing and crying (PLC) is a condition similar to euphoria where an
individual's affective expression is dissociated from the underlying emotion and not
necessarily appropriate to the social context. Mood states can also appear to fluctuate
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rapidly and the affect on the individual and those close to them can be very debilitating.
Prevalence of PLC within the MS population is approximately 10% (Feinstein et al,
1997). As with euphoria, it is assumed to be a symptom characteristic of late-stage MS
and is associated with greater physical and cognitive disability (Mohr and Cox, 2001).
Psychotic Symptoms
Symptoms akin to psychosis are thought to affect 2-3% of the MS population (Patten et
al, 2005). Feinstein et al (1992) reported that episodes of psychosis in the MS population
tend to occur in people who are older than would be typical of schizophrenia and who are
experiencing the late stage of the disease. Furthermore, the presentation of psychotic
symptoms has been associated with lesions located around the temporal horns (Ron and
Logsdail, 1989).
Aetiology ofAffective Disorders in MS
Identifying the specific causes underlying the development, onset and maintenance of
affective disorders in MS is complex. It is most likely that "psychotic and emotional
symptoms are due to an interaction of biological, psychological and social factors"
(Brassington and Marsh, 1998).
A number of researchers propose that in MS affective disorders, like those amongst the
general population, are essentially psychosocial. They arise as a reaction to an adverse
life event and are mediated by pre-morbid as well as existing variables. Indeed, MS can
be characterised by the recurrent onset of psychological stressors - physical functioning,
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social role and social support can all be compromised by the disease (e.g. Pakenham,
1999; Halper, 2007).
In support of the causal role played by psychosocial factors in the development of
affective disorders, Shnek et al (1995) reported no relationship between depression and
either disease activity or magnitude of disability as measured by the EDSS. Rather,
depression was associated with measures of learned helplessness, cognitive distortions
and reported self-efficacy. Moller et al (1994) found similar results, reporting that
depression was not related to demographic variables (age and gender), illness duration
nor level of physical disability. Furthermore, Feinstein (2002) reported that factors
increasing the risk of suicidal ideation in people with MS were "similar to those in the
general population, namely the presence and severity of major depression, alcohol abuse,
and social isolation".
Other researchers provide evidence to suggest that the affective disorders in MS are the
consequence of an underlying organic cause, the pathological demyelination process and
subsequent neurological damage. George et al (1994) report a positive correlation
between clinical depression and lesion load within the cortical white matter of the left
hemisphere. As reported above, Ron and Logsdail (1989) found that MS patients who
had psychotic symptoms had greater lesion load around both temporal horns than non-
psychotic MS controls. Feinstein et al (1992) also noted increased lesion prevalence
around the temporal horns in a sample of ten MS patients with psychosis relative to ten
MS patients without psychosis. Mahler (1992) proposed that euphoria may emerge as a
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consequence of extensive cortical scarring disturbing communication between the frontal
cortex and the limbic and diencephalic regions. Also, as reported above, euphoria and
PLC typically only present in MS patients who have significant neurological impairment
(Kesselring and Klement, 2001; Mohr and Cox, 2001).
1.2.2.2 Cognitive Symptoms
Over recent years, cognitive changes due to MS have received widespread attention from
researchers. It is now widely understood that cognitive deficits are common amongst the
MS population and that these deficits emerge as a consequence of the disease process.
Rao, Leo, Bernardin et al (1991) reported a 40% prevalence of cognitive impairment
within a community-based sample.
The variability of lesion location within the CNS means that patterns of cognitive change
are highly idiosyncratic. For instance, an individual who has significant scarring of the
spinal cord may be profoundly physically disabled and yet free from cognitive
impairment. Consequently many researchers highlight the risk of assuming that people
with MS are a homogenous population with regards to cognitive functioning and
cognitive impairment.
A number of studies have charted the natural history of cognitive change within an MS
population. Kujala, Portin, and Ruutiainen (1997) completed baseline assessment on an
MS cohort (n = 42) and identified them as either cognitively preserved (n = 20) or mildly
impaired (n = 22) on a range of neuropsychological tests. At follow-up three years later,
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the intact group were still equivalent to healthy controls (n = 34) on cognitive assessment,
whereas the impaired group had deteriorated further since baseline assessment. The
authors therefore concluded that baseline cognitive impairment is a good predictor of
future cognitive functioning.
Amato et al (1995, 2001) completed a baseline cognitive assessment with 50 MS
participants and repeated it at four and ten year follow-up. They found that, relative to 70
healthy control participants, cognitive deficits were detected in the MS group, even
amongst those who had only recently been diagnosed. The investigators reported
stability of cognitive ability; cognitive performance did not significantly change at four-
year follow-up even amongst those who initially presented with mild impairment.
Duration, course and level of impairment were poorly correlated with clinical outcome.
However, at ten-year follow-up, cognitive impairment was more marked and fewer
members of the cohort remained cognitively intact. At this stage, correlates of cognitive
change were more pronounced and included physical disability, disease course, and
increasing age. Those with a progressive form of the disease typically perform worse on
cognitive assessments (Feinstein, Kartsounis et al, 1992). However, Feinstein, Ron and
Thompson (1993) reported that people with identical disease course and MRI results can
still demonstrate considerable variability on test performance.
The onset of relapse can interfere with cognitive performance. Foong et al (1998)
measured cognitive ability during acute relapse and then again six weeks later. They
noted that impairment was more marked during relapse although the effects were not
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necessarily permanent; there was some recovery of function at six week follow-up
although this was not always complete.
Key areas ofcognitive change
The outcome of studies utilising neuropsychological assessment measures to identify
specific cognitive markers are discussed below.
Memory
Memory impairment is common in MS although its presentation varies. Beatty et al
(1996) found a wide range of memory performance in their MS sample (n = 99). A
quarter had no memory problems evident on testing; just over half presented with mild to
moderate memory impairments; and just over one fifth of the sample presented with a
"severe amnesia-type" impairment. Many investigators have sought to determine the
specific characteristics of memory impairment in MS. There is considerable evidence to
support the argument that memory failure in MS is the consequence of an inability to
spontaneously retrieve information from long term memory (LTM) (e.g. Rao et al, 1993;
Armstrong et al, 1996). These studies demonstrated that immediate recall, recognition
and rates of forgetting were intact, thereby implying a retrieval deficit. An alternative
explanation was offered by DeLuca et al (1994) who argued that it was not retrieval but
impaired initial learning causing memory difficulties. To control for this they allowed
MS participants more trials to learn new information and found that following this
retrieval and recognition abilities were equivalent to controls.
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Thornton and Raz (1997) conducted a quantitative review ofmemory impairment in MS,
concluding that there is "significant impairment across all memory domains" (pg 357).
They report that the disparity and contradiction within the literature appears to reflect the
heterogeneity of the MS population and differing assessment methods.
Attention & Concentration
Like memory, attention and concentration are generally considered to be multi-faceted
concepts (e.g. Yantis, 1998). De Sonneville et al (2002) assessed performance of people
with MS on tasks of focused, divided and sustained attention. They found that people
with MS were more impaired across all tasks than healthy controls. They also found
variance between the performances of different MS sub-types: secondary progressive
patients had the most extensive deficits, followed by primary progressive patients,
followed by relapsing remitting patients.
Rao, Leo, Bernardin et al (1991) found similar results. On a battery of different tests of
attention, patients with MS routinely scored worse than controls. The difference was
significant on four of the five tests administered. Beatty et al (1996) reasoned that
impaired auditory attention could realistically underlie the observed dysfunction of




It has been reported that MS typically causes a general slowing of information processing
speed (Kujala et al, 1994; Kail, 1998). De Sonneville et al (2002) developed these
findings to report that slowed information processing speed was further compounded by
increased task complexity (requiring greater cognitive effort) and the presence of
distracters.
It has been proposed that the differences in information processing observed between MS
patients and controls could be an artefact of physical disability (Jennekens-Schinkel et al,
1988a,b). However differences remain in performance between MS samples and controls
even when the physical requirements of a task are controlled for (Rao et al, 1989). This
suggests that impaired information processing is a central characteristic of impaired
cognitive functioning in MS which can then have a consequential affect on other
cognitive skills.
Executive Functioning
The executive functions can be characterised as the higher-level cognitive skills that
mediate other intellectual operations. Broadly speaking they include initiation of activity,
planning, implementing, and monitoring an activity, and adapting to solve novel
problems (e.g. Lezak, 2004). The impaired performance of people with MS on tests of
executive function has been well documented (e.g. Foong et al, 1997; Arnett et al, 1997).
Some researchers have proposed that euphoria, one of the affective disorders associated
with MS (see section 1.2.2.1), could be a behavioural manifestation of impaired executive
functions (Foong et al, 1997).
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Beatty and Monson (1996) commented that impaired performance of people with MS on
the Wisconsin Card Sort Test (WCST) was likely to be due to deficient concept
formation rather than perseveration. MS patients also perform worse than controls on
tests of verbal reasoning, independent of verbal ability (Beatty and Hames et al, 1995).
Foong et al (1997) found that planning ability, assessed using a modified version of the
Tower of London (Shallice, 1982), was impaired in a cohort of 42 MS patients compared
to 40 healthy controls. Closer investigation of their results shows that people with MS
were less cognitively efficient. Although the MS group reached the correct goal, the
route they took contained more errors, reflecting less effective skills of planning and self-
monitoring. Arnett et al (1997) administered an equivalent test of planning and reported
that the impaired performance of the MS group was a likely consequence of both
impaired planning and slowed information processing speed.
Insight
Neurological dysfunction has been associated with impairment of an individual's
awareness of their own cognitive, physical, and functional difficulties. As a consequence
of this, subjective accounts of neurologically impaired patients can be unreliable (e.g.
Simpson and Schmitter-Edgecombe, 2002). Impaired insight has been reported in MS.
For example, Goverover et al (2005) collected data about neurobehavioural impairment
from both MS patients (n = 24) and informants (i.e. people who knew the participant
well). They compared the two subjective reports and found that greater cognitive
21
impairment was related to increased disparity between the two reports. Similarly, Beatty
and Monson (1991) found that MS patients who were impaired on assessment ofmemory
function were less likely to report any memory difficulties. Randolph et al (2004)
compared MS patient's actual performance on memory tests with their subjective reports
of memory impairment. They found that self-report accuracy was influenced by
cognitive and affective variables in MS patients. Specifically, executive impairment,
depression and dysfunctional depressive attitudes were associated with reports of
increased memory dysfunction.
Neuroanatomical Correlates ofCognitive Impairment
The high prevalence of cognitive impairment in MS samples is perhaps unsurprising
given the outcome of studies that attempt to understand relationships between cognitive
functioning and lesion activity and location. Using tools such as Magnetic Resonance
Imaging (MRI), researchers have discovered an association between global cognitive
impairment and the pattern of lesions within cortical and subcortical brain structures, as
described in section 1.3.1. Bermel et al (2002) found that whole brain atrophy is greater
in MS than controls and atrophy is associated with cognitive performance. Baumhefner
et al (1990) identified total plaque burden within the cerebrum as an indicator of
neuropsychological functioning, whereas Huber et al (1992) and Edwards et al (2001)
noted that severe cognitive impairment accompanied significant atrophy of the corpus
callosum. Severe cognitive impairment has also been associated with lesion burden
within periventricular white matter and the width of the third ventricle (Pozzilli et al,
1991; Benedict et al, 2002).
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Additional neuroanatomical investigations have sought to identify relationships between
particular lesion sites and specific cognitive impairments. For example, impaired
functioning of the corpus callosum has been attributed to poor performance on tests of
information processing speed, rapid problem solving (Rao, et al, 1989), and impaired
visuo-spatial ability (Ryan et al, 1996). Extensive demyelination of the periventricular
white matter has been observed to cause dysfunction of memory (Maurelli et al, 1992;
Anzola et al, 1990), concept formation and non-verbal reasoning (Anzola et al, 1990).
Poor performance on tests of conceptual reasoning has also been attributed to lesions in
the white matter of the frontal lobe (Swirsky-Sachetti, Mitchell et al, 1992; Arnett et al,
1994). Lesions within the frontal and parietal lobes have been implicated in poorer
performance on measures of complex attention, working memory (Sperling et al, 2001)
and cognitive flexibility (Pujol, 2001).
1.2.2.3 Psychosocial Functioning
The symptoms of MS interfere with everyday functional activity. Social and vocational
activities in particular can become significantly compromised. Between 50 and 80% of
people with MS are unemployed ten years after the onset of the disease (Rao, Leo,
Ellington et al, 1991). Consequently, financial stressors may emerge. Furthermore, such
stressors are not always limited to the experiences of the individual with MS. Close
interpersonal relationships may also be affected and long-established roles required to
change; a spouse may need to become a caregiver for example.
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These observed psychosocial changes can be attributed to both physical and cognitive
consequences of MS. However, a number of researchers have proposed that cognitive
change is the most important factor in predicting social and vocational activity.
Rao, Leo, Ellington et al (1991) examined psychosocial functioning in two MS groups,
those who were cognitively intact (n = 52) and those who were cognitively impaired (n =
48). The two experimental groups were equivalent in terms of other disease
characteristics, including physical disability. They found that the cognitively impaired
group had greater disturbance of their activities of daily living, required greater assistance
from others and were less likely to engage in social activities. Amato et al (1995, 2001)
reported similar findings and argued that cognitive rather than physical change was the
best predictor of impaired social and vocational functioning.
Cognitive impairment in general terms and executive functions in particular, could have a
significant role in mediating social functioning. Impairment of executive skills could
manifest behaviourally as an inability to effectively monitor one's own behaviour
resulting in a failure to appropriately respond to social cues, leading to social
indiscretions. Consequently a person with deficits of executive functioning could
become estranged from partners, encounter difficulties interacting in the workplace and
become alienated from social groups.
1.3 Affect Recognition
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From the evidence in the previous section it is clear that MS is associated with
deterioration in the quality of social and vocational activities. These detriments are
thought to be related primarily to aspects of cognitive impairment, executive functioning
in particular. The ability to recognise the affective state of other people is a skill vital to
successful social interaction and can become compromised by impaired executive
functioning (e.g. Goldberg, 2001). Inability to perceive or interpret the emotional states
of others could result in inappropriate social behaviour, affecting interpersonal
relationships and vocational activity.
1.3.1 Emotion Theory
Emotions can be defined as affective states that are elicited in response to particular
environmental stimuli. Emotions are manifest in many different ways. Verbally, speech
content can be a potent indicator of emotion. The aural features of speech such as pitch
and intonation (prosody) can also provide information on emotion. Non-verbal
information such as gesture, poses and facial expression are also powerful cues to
underlying emotional states. Of these verbal and non-verbal expressions of emotion,
facial expression is arguably the most accurate barometer of underlying affect. This is
thought to be because facial expressions are reflexive and difficult to inhibit in situations
where true feelings are disguised (e.g. Ekman and Friesen, 1969; Ekman, Friesen and
O'Sullivan, 1988; Ekman, Friesen and Scherer, 1976). Consequently it could be argued
that recognition of facial expression is an important tertiary skill in mediating appropriate
social behaviour.
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Darwin's theory of evolution (as discussed by Ekman, 1992) suggested that behavioural
manifestations of emotional states are common to all humans irrespective of societal or
cultural influence because of our shared evolutionary heritage. Other theorists (e.g.
Klineberg, 1938) proposed that the learned association between behavioural expression
and underlying emotion was determined by cultural variables. Ekman (1968) and Ekman
and Friesen (1969) proposed that there is universality in the physical shapes made by the
muscles of the face when emotions are expressed. Elowever, they also commented that
individual cultural differences determine which events may stimulate different emotions.
Ekman and colleagues have conducted extensive research into the universality of facial
expressions of emotion. They observed that people from different cultural backgrounds
could match the same pictures of facial expression to the same emotion words (Ekman
and Friesen, 1969). Furthermore, following criticism that participants in their earlier
study may have been influenced by their exposure to mass media, the authors studied a
group of people living in remote communities in New Guinea (Ekman and Friesen,
1971). They used stringent exclusion criteria to ensure that only those who had had, at
most, minimal contact with Western cultures were included. They found that adults (n =
189) and children (n = 130) were able to match appropriate facial expressions to stories
about emotional events.
Ekman and colleagues identified six basic emotions, selected due to the ability of
participants in their cross-cultural studies to reliably discriminate between them. The
emotions identified were happiness, sadness, anger, disgust, fear, and surprise. They
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propose that these basic, universal emotions each have a distinct facial expression;
derivatives of these emotions share common features of the facial expressions. Smiling,
for example, is associated with happiness as well as other positive emotions such as
relief, amusement, and pride (Ekman, 1992b).
Techniques for measuring the ability to recognise emotion in others have often, though
not always, utilised the six basic emotions identified by Ekman. Procedures tend to
require that participants match a target item of affective expression with an emotion label.
Using this technique it has been possible to investigate the emotion recognition abilities
in different neurological and psychiatric populations.
1.3.2 Neuroanatomy of Emotion Recognition
Cerebral lateralisation ofemotion processing
Some debate remains regarding the cerebral localisation of emotional processing in
humans. This debate appears to concern the potential role played by the left-hemisphere
which has long been known to be the location of propositional language and damage to
this area can impair comprehension and expression of verbal communication (e.g.
Heilman and Gilmore, 1998). This has an impact upon the ability to process and express
emotional material presented verbally. Some researchers believe that the left-hemisphere
plays a more significant role in the processing of emotion. For example, Lee, Meador,
Loring et al (2004) support the valence hypothesis which posits that the left-hemisphere
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is superior to the right in processing all positive emotion, whereas the right-hemisphere is
dominant in processing negative emotion.
Studies of lateralised brain-injury populations provide evidence to show that the
localisation of emotional processing is unilateral; the right-hemisphere is dominant for all
aspects of emotional processing irrespective of valence (e.g. Borod et al, 1998). Included
within this is the processing and recognition of non-verbal gestures such as facial
expression and people with right-hemisphere damage have been shown to have
significant difficulty recognising emotion from facial expression (e.g. DeKosky et al,
1980; Cicone et al 1980; Bowers et al, 1985).
Right-hemisphere temporoparietal regions have been shown to have particular
significance to emotional processing (e.g. Bowers and Heilman, 1984). Indeed,
Hasselmo et al 1989 showed that cell clusters responsible for facial expression
recognition are located in the superior temporal sulcus. This has caused some researchers
to speculate that this is the location of a non-verbal affect lexicon (Bowers, Bauer, and
Heilman, 1993). This theoretical mechanism represents a catalogue of non-verbal
communicative signals and their emotional meaning. Hence damage to the right-sided
temporoparietal region can inhibit processing of non-verbal information.
The limbic system
The limbic system is a network of interconnected neural pathways concerned with the
primitive emotional and behavioural functions designed to preserve the species (Diamond
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et al, 1985). Crawford et al (1986) also implicated the limbic system in the recognition
of emotion from facial expression following their study of emotion recognition in the
dementias. It is comprised of many neuroanatomical components including the
amygdala, located near the rostral tip of the temporal lobe. The amygdala is thought to
be fundamental to the evaluation of emotion from facial expression (e.g. Adolphs et al,
2001; Anderson et al, 2000), fear and anger in particular (Baird, Gruber, Fein et al,
1999).
Bi-lateral amygdala damage has been found to impair recognition of various emotions
including sadness, anger, fear, surprise and disgust (Adolphs et al, 1999). Impaired
functioning of the amygdala has also been implicated in childhood developmental and
psychiatric disorders that feature social impairments as defining characteristics (Bauman
1991; Hendren et al, 1995). However, Hamann et al (1996) posited that facial
recognition is not solely dependent on the functioning of the amygdala. They said that
the developmental stage at which amygdala damage occurs has an important bearing on
the likelihood of subsequent impairment in recognition of facial emotion impairment.
Specifically, impairment is more likely if damage to the amygdala occurred during
childhood.
Frontal lobes
Whereas the cerebral cortex and limbic system have been implicated in emotional
communication and expression, the frontal lobes are known to be fundamental in
regulating emotional behaviour (e.g. Heilman, 1998). The frontal lobes have been shown
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to play a significant role in mediating behaviours necessary for successful social
functioning. Indeed, Wood (2001) reports that neurobehavioural disability, including
altered social behaviour and personality changes, are often associated with frontal lobe
injury. Mah et al (2004) found that socio-behavioural pathology was predictive of
impaired judgement of social interactions caused by damage to the frontal cortex.
Furthermore, Damasio et al (1991) reported that injury to the frontal lobes interferes with
the usual tendency that people have to avoid situations and stimuli which induce negative
emotional experiences. Frontal lobe damage has also been found to impair performance
on tests of social cognition. For example, Rowe et al (2001) found that patients with
unilateral frontal lobe damage (n = 31) were significantly impaired in their ability to
make inferences about the beliefs of others relative to 31 matched, healthy controls. It
has also been demonstrated that recognition of sarcasm is impaired in patients who have
damage to the prefrontal (n = 25) but not posterior (n = 16) regions (Shamay-Tsoory et
al, 2005).
1.3.3 Affect Recognition Deficits in Clinical Populations
Neurological Conditions
The notion that cognitive dysfunction such as executive impairment may underpin
observed deficits in social functioning has been investigated in several neurological
populations. Traumatic brain injury (TBI) has received particular attention. McDonald
and Flanagan (2004) asked their sample of patients with severe TBI to watch a series of
video-taped vignettes showing social interactions. They were then required to make
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inferences about the speaker's emotions, beliefs, sincerity, and attempts to influence the
opinions of the person to whom they were talking. Results showed that patients had
considerable difficulties, except where the information was explicitly provided.
Green et al (2004) used a sample of patients with recently acquired TBI (n = 30). They
observed that on a test of non-emotional facial perception the performance of their
clinical sample was the same as an age-matched healthy control group (n = 30).
However, when required to make judgements about facial emotion, the experimental
group performed significantly worse than the controls. This implied that recognising
emotional states in others is susceptible to the affects of neurological damage.
Saunders et al (2006) recorded physiological responses to pictures that varied in their
level of affective valence. In their sample of 13 males with severe TBI the level of
physiological reaction to emotionally unpleasant pictures was significantly lower than the
healthy controls (n = 24). The TBI group also exhibited lower arousal levels in reaction
to the unpleasant pictures. The authors concluded that this pattern of physiological
reactivity in the TBI group related to underlying impairment in executive functioning
including apathy and a lack of responsiveness to emotional state in others.
Using 26 patients who had undergone unilateral temporal lobectomy (15 left-sided, 11
right-sided), Adolphs et al (2001) assessed ability to recognise basic emotion from facial
expression and prosody relative to a control group of 50 TBI patients. They found that
patients with right-sided temporal lobectomy were significantly worse at recognising
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negative emotions, fear in particular, from pictures of faces. No such differences were
found between groups on tests of prosody.
Difficulty in recognising emotion has been observed in several populations with acquired
neurological diseases. Sprengelmeyer et al (1996) observed that people with
Huntington's disease had difficulty recognising negative emotions from pictures of facial
expression. Most striking was their significant difficulty in recognising disgust, their
level of accuracy being no better than chance.
Adolphs et al (1998) reported that people with Parkinson's disease (PD) performed
entirely normally on assessment of recognition of emotion from facial expression.
However, a more recent publication by Suzuki et al (2006) contested this finding. Using
a refined assessment method, they reported that their PD sample (n = 14) was specifically
impaired in their ability to recognise disgust relative to demographically matched healthy
controls (n = 39).
Crawford et al (1986) reported on emotion recognition abilities in the dementias. They
found that people with multi-infarct dementia performed significantly worse than controls
on a test of affect recognition. Furthermore, this clinical group also performed
significantly worse than patients with Alzheimer's type dementia. Indeed, the
Alzheimer's group did not exhibit any impairment of facial emotion recognition. The
authors also report a discrepancy of performance on this test between people with
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Korsakov's syndrome and those with alcoholic dementia. Whereas the former group
were significantly impaired relative to controls, the latter group were not.
Psychiatric Conditions
The outcome of studies investigating the emotion recognition abilities of various
psychiatric populations suggests that affective states may be related to emotion
recognition.
Mandal and Battacharya (1985) reported that patients with depression made more errors
than controls when recognising negative (specifically sad) emotions. It was also noted
that the experimental group were more inclined to label emotions that they were unable to
recognise as sad. This response bias amongst psychiatric populations has been reported
by other investigators. Gur et al (1992) noted that patients with depression (n = 14)
recognised significantly more sadness in facial expressions than did healthy controls (n =
14). Surguladze et al (2004) reported on emotion recognition abilities of people with
major depression. They found that major depression interferes with the ability to
accurately recognise either sad or happy faces.
This affective response bias has also been noted in patients with mania (Lembke and
Ketter, 2002). In this study the manic participants with bipolar I (n = 8) were found to be
significantly worse at recognising negative emotions (fear and disgust in particular) than
healthy controls (n = 10). Overall, their recognition of emotion skills were more
impaired than two other clinical groups, euthymic patients with bipolar I (n = 8), and
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patients with bipolar II (n = 8). Harmer et al (2002) observed that patients with bi-polar
disorder (n = 20) were significantly better at recognising disgust than healthy controls (n
= 20), suggesting a heightened sensitivity to this negative emotion. The authors
hypothesised that this could relate in some way to the clinical features of bi-polar
disorder such as low self-esteem. A response bias was also noted in alcoholics who were
more inclined to inaccurately label sad faces as hostile (Frigerio et al, 2002). The authors
suggested that this may in some way explain some of the anti-social behaviours observed
in this population.
Schizophrenia is often associated with impaired social functioning. Feinberg et al (1986)
found that their sample of schizophrenic patients were more impaired than a sample of
depressed patients on assessment of both affect recognition and emotion labelling.
Similar results were found by Addington and Addington (1998) who reported that facial
affect recognition was more impaired amongst a schizophrenia group (n = 40) than either
a bipolar (n = 40) or healthy control group (n = 40). Heimberg et al (1992) assessed
schizophrenic participants' (n = 20) ability to discriminate between emotional and neutral
faces. Generally, they performed worse than healthy controls (n = 20) on this task, being
more inclined to infer that neutral faces were emotional. Potentially, delusions and
paranoia, symptoms often common within this group, could be characterised as the result
ofmisattributing emotional information to otherwise neutral circumstances.
Many of the authors involved in the investigation of affective recognition skills within
psychiatric populations have concluded that deficits in this area may underlie observed
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impairments in social functioning. Consequently, the psychiatric symptoms are
exacerbated and more likely to persist.
1.3.4 Affect Recognition in MS
The ability of people with MS to recognise emotional states in other people has so far
received very little attention. To date, there are only two published articles investigating
this area.
Beatty, Goodkin, et al (1989) aimed to examine the emotional processing abilities of
people with relapsing/remitting MS, chronic MS and Parkinson's disease. They also
sought to determine whether depression influenced the emotional processing abilities of
these two neurological groups. The relapsing/remitting MS group (RR MS) comprised
42 participants. The chronic progressive MS group (CP MS) comprised 21 people.
Chronic was defined as "observed deterioration in neurological status over a minimum of
6 months" (pg 391). The Expanded Disability Scale (EDSS, Kurtzke, 1983) and the
Ambulation Index (AI, Hauser et al, 1983) were used to measure change over time. In
the PD group were 43 participants, each of whom had at least two of five listed
disturbances of motor functioning. Participants were excluded if they had a history of
major psychiatric illness, drug or alcohol abuse, head injury, or CNS disease other than
MS or PD. Each clinical group was matched to a neurologically healthy control group
recruited from the community. The two control groups were smaller than both clinical
groups: n = 19 for the CP MS group; n = 27 for the PD group. The RR MS control group
sample size was not reported.
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Beatty, Goodkin, et al (1989) found that relative to their respective control groups, the
CP MS and PD groups scored significantly higher on assessment of depression (measured
by the Beck Depression Inventory, BDI, Beck et al, 1961) and lower on assessment of
cognitive ability (measured by the Mini-Mental State Examination, MMSE, Folstein,
Folstein and McHugh, 1975). Both groups were also significantly worse than controls at
discriminating neutral faces on the Benton Facial Recognition Test (BFRT, Benton et al
1983). Judgements of facial expression were measured using the materials of Ekman and
Friesen (1976). Administration of individual photographs of faces was self-paced
reportedly to make the task less effortful. Both groups were again significantly worse
relative to their respective control groups on this task. The RR MS group was found to
be equivalent to their control group on performance on each assessment apart from the
BFRT where a mild impairment was noted.
Significant correlations were found between all groups' performance on the affective
judgement task and performance on the BFRT. No such relationship was found between
affective judgement task performance and either depression score or cognitive ability.
This lead the authors to conclude that the "central mechanisms that allow accurate
labelling of affective states remain largely intact in MS and PD, but the accuracy of the
operation of these mechanisms is defective" (pg 363). They also postulated that affective
judgement is possibly secondary to discrimination of facial stimuli given the relationship
between scores on the BFRT and the affective judgement task. Therefore they implicated
impaired operation of the optic pathway in explaining the observed results. They did not
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report a possible explanation as to why there was a difference between the two MS
groups.
Beatty, Goodkin, et al (1989) also reported that although no affect of depression was
observed it cannot be ruled out as the BDI was perhaps not the most accurate measure of
depression for either of these two clinical groups given that many of the items relate to
physical impairment.
The authors concluded that functional impairment would not necessarily present as a
consequence of impaired recognition of affect from facial expression as other non-verbal
and verbal cues can be used to inform judgements. However, they suggested that
additional assessment of clinical participants' interaction with others would have been of
value in this regard.
More recently, Beatty, Orbelo, et al (2003) investigated the ability of people with MS to
judge emotional states from verbal information. Their experimental cohort consisted of
47 MS patients of varying cognitive ability; the control group (n = 19) was made up of
hospital staff and the friends and family of the participants. The hearing of all
participants was assessed. All members of the experimental group also underwent
cognitive and mood assessment.
During the first trial, affective prosodic comprehension, participants were asked to judge
emotional information from spoken sentences. The sentences varied according to how
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particular words were intoned, inferring one of six affective states: happy, sad, angry,
surprised, disinterested, and neutral. Participants were required to identify the affective
state they most closely associated with each sentence. The difficulty of this task was
increased through substitution of the sentence words with either monosyllabic (ba-ba-ba)
or asyllabic (aaahhhh) sounds. In this way the participant's judgement was reliant upon
identification of intonation alone.
In the second trial, affective prosodic discrimination, the experimental sentences were
adapted to reduce the phonetic information whilst retaining the stress and intonation
patterns associated with the six affective states. Sentences were then paired up. The
sentence pairs were played to the participants who had to judge whether the affective
state was the same or different in each sentence.
The control group performed significantly better than the MS group on the monosyllabic
and asyllabic conditions of the affective prosodic comprehension trial. They were also
significantly better on the prosodic discrimination trial. Therefore Beatty, Orbelo, et al
(2003) reported that the MS group were less able to identify emotional states from
prosodic information than controls. The authors also concluded that the results were
independent of cognitive and emotional functioning as the results of the MS group on the
prosodic experimental tasks did not correlate with their performance on cognitive or
mood assessment. This absence of an association is perhaps surprising given the
evidence to suggest that psychiatric conditions can influence affective judgements.
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1.4 Summary, Aims and Hypotheses
1.4.1 Summary
Multiple sclerosis is a degenerative neurological disorder. It is not uncommon for people
with MS to experience cognitive and emotional changes as a consequence of the
neurological changes associated with the disease. Psycho-social functioning, including
occupational activity and inter-personal relationships, can also be impaired by MS.
One area of cognitive functioning that has received little research attention is the capacity
of people with MS to accurately recognise emotion from facial expression. Such a deficit
could reasonably be expected to impair social functioning and in turn the quality of social
relationships. Impaired emotion recognition has been observed in various neurological
and psychiatric populations. Beatty, Goodkin, et al (1989) and Beatty, Orbelo, et al
(2003) have demonstrated that people with MS are impaired in their ability to recognise
emotional states from prosody and facial expression.
1.4.2 Aims
The primary aim of this research paper is to develop the existing literature on the emotion
recognition abilities of people who have MS. The principal question under investigation
is: do people with Multiple Sclerosis have difficulty recognising emotion from facial
expression relative to normative data collected from a sample of neurologically healthy
controls?
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The principle tool used to objectively measure facial expression recognition ability will
be the computerised neuropsychological test, the Facial Expression of Emotion: Stimuli
and Tests (FEEST, Young, Perrett, et al, 2002). The normative data collected from a
sample of healthy adults by the authors of the FEEST can be used in order to compare the
performance of the experimental group. There is no literature as yet published which has
used the FEEST with an MS population.
One of the secondary aims of the research project is to investigate how a deficit in the
recognition of facial expression may manifest functionally, affecting everyday social
behaviour. The current study will measure everyday functional performance using the
Brock Adaptive Functioning Questionnaire (BAFQ, e.g. Dywan and Segalowitz, 1996).
1.4.3 Hypotheses
The following hypotheses are under investigation:
(1) People with MS will be significantly worse at recognising emotion from facial
expression in comparison with normative data.
(2) Impaired recognition of emotion from facial expression will be correlated with
impaired functional behaviour.
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(3) Reports of MS participant's level of social functioning will vary according to the
information source - informants will report a significantly greater number of




The study was an independent samples design, comparing an experimental group of




A total of 30 participants were recruited to the experimental group. Details of the
recruitment procedure can be found in section 2.4.1. Demographic characteristics are
described in section 3.2.
2.2.2 Criteria for Participation
The criteria for participation within the study are outlined below:
Inclusion Criteria:
• diagnosis ofMS given by a consultant neurologist;
• aged between 20 and 70;
• estimated IQ of 90 or higher based on the NART;
• score of 15 or higher on the Shape Detection Test from the VOSP, used to
measure visual acuity and shape detection;
• score of 11 or below on both the anxiety & depression scales of the HADS; and
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• fluent in English and not aphasic.
Exclusion Criteria:
• recent MS relapse (i.e. within the previous four weeks);
• medically unfit to participate (determined by the referrer);
• history of neurological dysfunction (e.g. Parkinson's disease, drug/alcohol abuse,
brain injury, learning disability, dementia) other than MS;
• presence of current significant psychiatric difficulties; and
• presence ofmarked visual and/or auditory impairment.
2.2.3 Normative Data
The data collected from the MS group was compared with published normative data from
the primary outcome measure, the Facial Expressions of Emotion: Stimuli and Tests
(FEEST, Young, Perrett et al, 2002). The FEEST comprises two assessments. The first
of these, the Ekman 60 Faces, has normative data based on an opportunity sample of 227
healthy participants aged between 20 and 70. The second measure, the Emotion
Elexagon, has normative data based on an opportunity sample of 125 healthy participants
aged between 20 and 75.
2.2.4 Demographic Information
The demographic information recorded for each MS participant included:
• date of birth;
• gender;
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• date of diagnosis and MS sub-type (if known); and
• present MS medication.
The name and contact address of the participant's general practitioner were also recorded
so that they may be informed of their patient's participation as advised by the local area
ethics committee.
2.2.5 Informant Details
The name and contact details of a significant other were also recorded. This person was
nominated by the MS patient as the informant who would complete the parallel form of
the Brock Adaptive Functioning Questionnaire (BAFQ) about the MS participant.
2.3 Measures
The present study made use of five clinical measures across the screening and
experimental trials. These measures are outlined in more detail below.
2.3.1 Screening Trial
2.3.1.1 The National Adult Reading Test (NART Nelson, 1991)
The NART is a reading test comprising a set of 50 irregular words which the participant
is asked to read aloud. The total number of mispronunciations is summed to create a
NART error score, ranging from 0-50. NART performance significantly correlates with
general intellectual functioning as measured by the Wechsler Adult Intelligence Scales -
Revised (WAIS-R, Wechsler, 1981). The total NART error score can be used as a means
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of predicting performance on the WAIS-R, thereby providing an estimate of general
intellectual ability.
In the present study the NART was used to estimate the intellectual abilities of the MS
participants. Completion does not require functional motor operation, an ability often
impaired in MS. It is also brief (administration takes approximately five minutes) and
non-threatening. Furthermore, the NART was used by authors of the FEEST to help
estimate the intellectual abilities of members of their normative sample. Those whose
predicted FSIQ was below 90 were excluded from the experimental trials, replicating the
exclusion criteria used by the FEEST authors during the collection of their normative
data. Therefore inclusion of the NART in the present study afforded parity with the
procedure used by the FEEST authors.
The NART is suitable to use with adults 18 - 70. It is supported by good evidence of
reliability and validity. Several studies have demonstrated the high levels of inter-rater
(0.96-0.98) and test-retest reliability (0.98) (O'Carroll, 1987; Crawford et al, 1989a;
Schlosser and Ivison, 1989b). It has also been independently verified as a valid measure
of general intelligence (Crawford et al, 1989a).
2.3.1.2 The Shape Detection Test from the Visual Object and Space Perception
Battery (VOSP, Warrington and James, 1991)
Impaired visual functioning is a common physical symptom of MS, as described in
section 1.2.1. The FEEST is a visually based assessment and performance on it could be
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affected by visual impairment. Therefore, the Shape Detection Test from the VOSP was
introduced to control for this.
The VOSP is a battery of tests designed to measure visual perceptual functioning. The
Shape Detection Test precedes administration of the other sub-tests. Failure on this
preliminary test contraindicates administration of the remaining sub-tests. It is derived
from the figure/ground perception test devised by Warrington and Taylor (1973) and is
sensitive to impaired visual acuity and shape detection but not other impairments of
object perception (Warrington and Taylor, 1973; De Renzi et al, 1989).
The screening test requires respondents to indicate whether they can or cannot see a
partially degraded X printed upon a speckled black and white background. The test is
comprised of 20 such items, preceded by two practice items which are used to illustrate
the procedure. The score range is 0-20. The authors recommend that a score of 15 or
below constitutes a fail based on their observation that the lowest score recorded by any
member of their brain-injured group was 17 (Warrington and James, 1991). The same
criteria were applied to the present study and those who scored below 15 were not invited
to complete the experimental trials.
2.3.1.3 The Hospital Anxiety and Depression Scale (HADS, Zigmond and Snaith,
1983)
As reported in section 1.3.4 of the introduction, mood disorder can interfere with
performance on tasks of affective judgement. In order to control for this, a formal
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assessment ofmood was included in the screening test. The HADS was selected as it is a
commonly used clinical and research tool, and is quick to complete and score.
Furthermore, according to Herrmann's (1997) extensive review of the HADS's
properties, it is well accepted amongst patients and has good reliability with internal
consistencies of 0.80-0.93 and 0.81-0.90 for the anxiety and depression sub-scales
respectively.
The HADS is comprised of 14 statements. Seven statements refer to symptoms of
anxiety (e.g. "I feel tense and wound up") and seven refer to symptoms of depression
(e.g. "1 still enjoy the things I used to enjoy"). The respondent decides how much they
agree with each statement by selecting one of four responses (e.g. Most of the time; A lot
of the time; Time to time, occasionally; Not at all), each of which corresponds with a
score of 0-3. Therefore, the total anxiety and depression sub-scale scores range from 0 to
21, and the total score from 0 to 42.
HADS scores can be interpreted through use of clinical cut-offs. The mood disorder is
categorised as mild, moderate or severe according to the raw score achieved on either the
anxiety or depression scales. The authors of the HADS, suggested that normal
functioning is reflected in a raw score of 7 or below; mild impairment is a score of 8-10;
moderate impairment is 11-15; and severe impairment is 16 and over (Snaith and
Zigmond, 1994).
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It has more recently been argued that these criteria overestimate the prevalence of mood
disorders within the general population. Crawford et al (2001) note that, using Snaith
and Zigmond's guidelines for classification, 33% of their healthy adult sample scored
outwith the normal range (i.e. a raw score of 8 or higher). This contrasts with a
prevalence of 13.9% for anxiety disorders within the general population reported by
Meltzer et al (1995). Crawford et al (2001) therefore recommend that a HADS raw score
of 11 or higher is a more valid marker of clinical 'caseness' as this more accurately
reflects the prevalence of mood disorder within the general population.
Therefore, participants in the present study who scored 11 or higher on either anxiety or
depression scales of the HADS were excluded from the remainder of the study due to the
probability that this reflected clinically significant levels of self-reported anxiety and/or
depressive symptoms.
2.3.2 Experimental Trials
2.3.2.1 The Facial Expression of Emotion: Stimuli and Tests (FEEST, Young,
Perrett et al, 2002)
The FEEST contains two tests of facial expression recognition, The Ekman 60 Faces and
The Emotion Hexagon. Both tests are derived from the emotion recognition work of
Ekman and Friesen (1976) who developed a set of photographs each of which showed a
facial expression of emotion. Each expression corresponded with one of the six basic
emotions: happiness, sadness, surprise, fear, disgust, and anger. As reported in section
1.3.2, these emotions had been identified as those which people can most reliably
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discriminate between throughout developed and developing nations. These materials
have been widely used in research into recognition of emotion from facial expression.
However, prior to the development of the FEEST, they had not been available as a
published test.
The FEEST is a computerised assessment and use of a personal computer is necessary for
test administration. Once the assessment has been completed all results are stored as an
Excel worksheet, which facilitates data analysis.
The procedure for completion of the Ekman 60 Faces Test and the Emotion Hexagon
Test is broadly similar. Participants are shown on a computer screen photographs of
faces, presented one at a time. Beneath each photograph are six buttons, each with one of
the six basic emotions written upon it: happiness, sadness, surprise, fear, disgust, and
anger. The participant decides which emotion the picture best represents. Each
photograph is displayed for five seconds only, although participants can take as long as
they need to provide an answer. A response must be entered before the next photograph
is displayed. The total number of correct responses is recorded. Examples of the
materials used in the Ekman 60 Faces and Emotion Flexagon tests can be found in
Appendix 4.
Responses can be recorded by clicking the appropriate on-screen button, by pressing
user-defined keys on the keyboard or by the experimenter inputting the chosen response
on the participant's behalf. In the present study this latter input technique was used
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exclusively in order to control for individual differences of motor dysfunction between
members of the experimental sample.
The Ekman 60 Faces Test comprises a total of 70 items - one experimental trial of 60
items preceded by ten practice items. The Emotion Hexagon Test comprises a total of
180 items - five experimental trials of 30 items preceded by one practice trial of 30 items.
Participants were able to rest for as long as necessary between administration of the two
tests and between trials of the Emotion Hexagon. This helped control for potential
affects of fatigue and distraction, common problems in an MS sample.
The Ekman 60 Faces Test
The authors of the FEEST selected the photograph sets of ten models, six female and four
male, from the original materials developed by Ekman and Friesen (1976). Each set of
photographs is comprised of six pictures, each corresponding with a different basic
emotion, i.e. each model is shown displaying each of the six emotions. The total score
range is 0-60, whereas the score range for each of the six constituent emotions is 0-10.
Normative data for the Ekman 60 Faces Test was derived from assessment of 227 healthy
participants aged 20-70 and with IQ scores (estimated using the NART if unknown) of 90
or above. The data comprise mean correct recognition rates, standard deviations and cut¬
offs identifying the boundary between normal and impaired performance for each of the
six basic emotions. Normative data for sub-groups categorised by age, gender, and
intelligence, are also reported.
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The Ekman 60 Faces Test has been demonstrated to be a reliable measure of emotion
recognition from facial expression. The authors report statistically significant split-half
reliability data for overall scores, recognition of anger, disgust, fear, sadness and surprise.
For recognition of happiness scores were at ceiling and so did not correlate significantly.
Reliability data are summarised in table 2.1.




Anger Disgust Fear Happiness Sadness Surprise
Correlation
(r)
0.62 0.62 0.66 0.53 0.21 0.60 0.61
Probability
(P)
<.001 <.001 <.001 <.001 >.1 <.001 <.001
The Ekman 60 Faces Test is a valid measure of emotion recognition from facial
expression. The normative data from this test correlate highly with that of Ekman and
Friesen (1976) (r=0.81, t=10.35, df 58,/?<.001). Furthermore, it has been shown to be
sensitive to impairments of facial emotion recognition in patients with amygdala damage
(Broks et al, 1998); basal ganglia lesions (Calder et al 2000b) and OCD (Sprengelmeyer
et al, 1997). It has also been used to demonstrate impaired ability to recognise emotions
within people who present with altered social behaviour following onset of a variant of
fronto-temporal dementia (Keane et al, 2002).
The Emotion Hexagon Test
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The images used in the Ekman 60 Faces Test represent broadly stereotypical expressions
of facial emotion. The ecological validity of this is debateable as real-life expressions are
rarely so easily defined. Therefore the Emotion Hexagon Test was devised to increase
item ambiguity by constructing new images through the blending of two pictures of
emotional expression. The decision as to which emotions would be blended was
determined through development of the emotion hexagon. The corners of the emotion
hexagon were occupied by one of the six basic emotions. Each emotion was adjacent to
the two emotions it was most likely to be mistaken for. For example, the emotion fear




Figure 2.1: The Emotion Hexagon. Each of the six basic emotions is adjacent to the
emotions with which it is most likely to be confused (Young, Perrett et al, 2002).
Disgust
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The images of facial expression which illustrated the emotions adjacent on the emotion
hexagon were blended together. Therefore there were six emotion pairs: happiness-
surprise; surprise-fear; fear-sadness; sadness-disgust; disgust-anger; anger-happiness. An
emotional continuum was developed by blending the constituent parts of the pairs
together in five different proportions: 90:10; 70:30; 50:50; 30:70; 10:90.
The authors applied this technique to one set of the Ekman and Friesen (1976)
photographs to create a new set of 30 images. In the test there are five experimental
trials. In each trial participants are shown the 30 images one at a time and asked to report
which of the six emotions each picture best represents. Only responses to the items
where one emotion is dominant (i.e. constitutes 90% or 70% of the image) are recorded.
Responses to the 50:50 blends are not recorded as they are too ambiguous, representing
as they do equal amounts of two emotional expressions. The total score range is 0-120
whereas the score range for each of the six constituent emotions is 0-20.
Normative data for the Emotion Hexagon Test were derived from assessment of 120
healthy participants aged 20-75 and with IQ scores (estimated using the NART if
unknown) of 90 or above. The data comprise mean correct recognition rates, standard
deviations and cut-offs identifying the boundary between normal and impaired
performance. Normative data for sub-groups categorised by age, gender, and
intelligence, are also reported.
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The Emotion Hexagon Test has been found to be a reliable measure of emotion
recognition from facial expression as summarised in table 2.2.




Anger Disgust Fear Happiness Sadness Surprise
Correlation
(')
0.92 0.68 0.92 0.88 0.18 0.65 0.33
Probability
(P)
<.001 <.001 <.001 <.001 >.1 <.001 <.001
Young et al (2002) compared the data from 67 neurologically healthy control participants
who had completed the Emotion Hexagon and Ekman 60 Faces. The two sets of results
were found to be significantly correlated. The results of this analysis are provided in
table 2.3. Furthermore, the Emotion Hexagon Test has been shown to be more sensitive
in identifying impairment in emotion recognition amongst a range of clinical populations
than the Ekman 60 Faces Test (Calder et al, 2000; Sprengelmeyer et al, 1999;
Sprengelmeyer et al, 1997a).




Anger Disgust Fear Happiness Sadness Surprise
Correlation
(>')
0.68 0.51 0.27 0.52 -0.05 0.54 0.42
Probability
(P)
<.001 <.001 <.05 <.001 >.1 <.001 <.001
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2.3.2.2 Brock Adaptive Functioning Questionnaire version 4 (BAFQ Dywan and
Segalowitz, 1996)
The BAFQ is a self-report questionnaire developed by Dywan and Segalowitz (1996) to
assess behavioural functioning in adults who had sustained traumatic brain injury
affecting operation of the frontal lobes. The original version of the questionnaire sought
to provide information on functional behaviour within five areas: Planning, Initiation,
Attention and Memory, Arousal, and Social Monitoring. A modified version was also
developed to increase specificity (Dywan, Roden, and Murphy, 1995). This includes
twelve sub-scales: Planning, Initiation, Flexibility, Excess Caution, Attention, Memory,
Arousal, Emotionality, Impulse Control, Aggressiveness, Social Monitoring, and
Empathy.
Each of the 68 items on the BAFQ is a statement reflecting a functional skill (e.g. Do yon
pay attention to whether others are following what you are saying?) The respondent
decides how much each statement reflects their current experience by selecting one of
five responses: Hardly ever; Rarely; Sometimes; Often; Almost always. Each of these
responses corresponds with a score of 1-5; a high score reflects greater impairment.
Clusters of items correspond with different sub-scales. This is summarised in table 2.4.
Total scale scores are calculated by summing the ratings for that scale and then dividing
by the number of responses given.
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Table 2.4: The twelve BAFQ sub-scales and corresponding items.
BAFQ sub-scale (item range) Representative number of items
Planning (1-7) 7
Initiation (8-11) 4
Flexibility (12 -15) 4
Excess Caution (16- 20) 5
Attention (21 —27) 7
Memory (28 - 35) 8
Arousal (36 - 40) 5
Emotionality (41 - 44) 4
Impulse Control (45 — 51) 7
Aggressiveness (52 - 56) 5
Social Monitoring (57 — 63) 7
Empathy (64 - 68) 5
TOTAL (1 - 68) 68
The BAFQ is comprised of two parallel forms, one to be completed by the participant,
the other by someone who knows them well who can act as an informant. Both versions
of the questionnaire are identical apart from the substitution of pronouns where
necessary. Comparison of scores on participant and informant versions of the BAFQ can
be used to provide information regarding the participant's awareness of deficits in
everyday functioning. Where participant and informant scores are approximately
equivalent this reflects a good level of awareness of deficits. However, if there are
significant discrepancies between the two versions then the participant's self-awareness is
likely to be compromised.
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The BAFQ is not yet commercially available as a published test but has been used in
several published studies with neurologically impaired samples, healthy control samples,
and informants. The test's author, Jane Dywan has reported that the BAFQ was designed
originally as a clinical tool to aid clinical interviews and allow for comparison between
past and present functioning following TBI and to provide an index of agreement
between the TBI survivor and a significant other (personal correspondence, May 2007).
The results are designed to be descriptive and there are as yet no identified cut-off scores
to indicate presence of specific pathologies.
Dywan, Roden, and Murphy (1995) provided evidence that the BAFQ can tap areas of
functioning controlled by different regions of the frontal system. They administered the
BAFQ to 199 healthy school children, aged 15-16. Outcome data underwent factor
analysis which identified two groupings. The first comprised Impulse Control, Memory,
Aggression, Emotionality, Arousal, Compulsiveness, Attention, and Initiation. The
authors speculated that these features related to function of orbitofrontal functioning.
The second grouping (Planning, Empathy, Initiation, Social Monitoring, and Flexibility)
was speculated to relate to dorsolateral functioning.
Simpson and Schmitter-Edgecombe (2002) used the BAFQ with adult TBI survivors (n =
61) and informants. They reported that there were significant positive correlations
between TBI survivor and informant data within the following scales: Planning,
Initiation, Flexibility, Compulsiveness, Attention, Memory, Empathy (all p values
<0.01), and Arousal (p<0.05). The authors noted the absence of significant correlations
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between survivor and informant data within the scales of Emotionality, Impulse Control,
Aggressiveness, and Social Monitoring. Informants rated these areas as more impaired
than the TBI survivors. They speculated that this may be evidence of the TBI survivors
reduced insight into existing social behaviours.
Hopkins et al (2002) administered the BAFQ to adult TBI participants (n =15), who
reported significantly more problems than age-matched, non-injured controls (n = 15) in
the areas of Flexibility, Memory, and Arousal (p<.01). Informants who completed
questionnaires about members of the TBI group reported significantly more problems
than the control informants in Planning, Initiation, Flexibility, Compulsiveness,
Attention, Memory, Arousal, Social Monitoring, Empathy (all p<.01), Emotionality and
Impulse Control (p<.05 for both). Again, this tendency for people with TBI to report
fewer difficulties relative to their informants probably reflects reduced self-awareness
amongst some TBI survivors.
A more recent study investigated BAFQ ratings and care-giver stress (Wells et al, 2005).
The BAFQ was completed by adult TBI survivors (n = 72) and their primary caregivers.
Informant ratings were highly predictive of the caregiver's disturbed mood, measured
using the Symptoms Checklist (adapted from the Symptoms Distress Checklist, SCL-90,
Derogatis, (1983) and negative feelings about providing care, measured using the
Caregiver Stress Questionnaire (adapted from the Zarit Burden Interview-Short Form,
Bedard et al, 2001; and the Questionnaire on Resources and Stress, QRS, Holyroyd,
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1985). This finding would appear to suggest that high BAFQ ratings are likely to in turn
reflect significant levels of caregiver distress.
In the present study the BAFQ was used to provide a subjective measure of functional
behaviour. It was used as an adjunct to the data from the FEEST which represents an
objective measure of emotion recognition. The BAFQ was completed by all participants




During routine clinical work referrers (including consultant neurologists, MS nurse
specialists, speech and language therapists, and psychologists) mentioned the research
project to patients who appeared to fit the inclusion criteria provided by the investigator.
At this time the referrer also passed on a Participant Information Sheet which provided
details of the aims, rationale and procedure of the research project (see Appendix 2).
Those who were interested gave verbal consent for their name and contact details to be
passed to the lead researcher. The lead researcher then made telephone contact to invite
participants to attend the screening appointment.
2.4.2 Screening Trial
The following screening process, which lasted between 30 and 40 minutes, was
undertaken with all potential participants and comprised:
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• a reminder of the aims and procedure of the research project plus an opportunity
to ask questions;
• completion of the consent form by those who chose to participate(see Appendix
2);
• collection of the demographic information listed above was through brief clinical
interview;
• administration of the NART, HADS and the VOSP Shape Detection Test (N.B.
where participants had difficulty with pen control, the lead researcher assisted in
completion of the written tests); and
• an offer to take part in the experimental trial given to all participants scoring
above the clinical cut-offs on both the NART and VOSP, and below the clinical
cut offs on the HADS.
2.4.3 Experimental Trial
The experimental trial was timetabled to take place within seven days of the screening
trial where possible. During the experimental trial both tests of the FEEST, the Ekman
60 Faces and the Emotion Hexagon, were administered. This took between 45 and 60
minutes. Data collected from participant's completion of the FEEST were allocated a
code to facilitate anonymity. Data were stored on the hard drive of the computer used for
administration.
During the experimental trials the following procedure was adhered to:
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• instructions were shown to the participant and read aloud by the lead researcher
prior to administration of both tests of the FEEST;
• participants then given time to ask questions before the start of the practice trial;
• administration of the FEEST;
• participant provided verbal responses to each FEEST item which the lead
researcher then entered into the computer;
• opportunity for the participant to take a break between practice and experimental
trials;
• debrief about the project and explanations provided about the materials used once
the FEEST administration had been completed;
• distribution of the BAFQ, a version for themselves and a parallel form to be
completed by an informant nominated by them during the screening trial;
• BAFQ orientation, instructions given on how to complete it and request made that
they complete the BAFQ independently and in their own time; and
• participants asked to return completed forms to the lead researcher in the stamped,
addressed envelope provided.
2.5 Ethical Considerations
The main ethical consideration for the present study was potential distress caused by
identifying a hitherto unknown cognitive impairment without being able to provide any
subsequent support. To protect against such eventualities several precautions were taken.
Prior to giving written consent, participants were made aware that:
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• no individual feedback of results could be given, although a summary of the
study's findings could be sent to their correspondence address if requested;
• there was no direct personal benefit from participation; and
• their General Practitioner would be alerted to their involvement in the study.
Should a mood disorder be detected, individuals were reminded of the services available
through their referrer but told that no treatment could be accessed through participation in
the study. In general, the overall risk of distress caused by participation was thought to
be very low.
Ethical approval for the present study was granted by Lothian Research Ethics
Committee (see Appendix 3 for a copy of the Ethics Committee approval letter).
2.6 Data Analysis
The data collected from the FEEST underwent single-sample t-test analysis to establish
statistical differences between the experimental sample and normative data. Correlation
analysis was completed to establish relationships between FEEST outcome and scores on
the twelve sub-scales of the BAFQ. Repeated measures t-tests were completed to
determine whether there were significant differences between the self- and informant-
reports on the BAFQ.
2.7 Statistical Power
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The primary aim of this study was to investigate whether people with MS are impaired at
recognising emotion from facial expression. Beatty et al (1989) had similar aims and so
effect sizes from this study were used in power calculations to determine the sample size
required by the current study.
Beatty et al (1989) compared a group of patients with progressive MS (n = 21) and
healthy controls (n = 19) on a test of facial affect recognition. The means and standard
deviations for both group's performance on the test are presented in table 2.5.
Table 2.5: Means and standard deviations of the MS and control groups on a test of
facial affect recognition (Beatty et al, 1989).
Mean Standard deviation
MS group (n = 21) 75.0 13.4
Controls (n = 19) 90.4 11.2
A significant difference was noted between groups (F( 1,38) = 15.29, p < .001) with a
large effect size of d=1.24 (calculated using a pooled standard deviation of 12.42).
Therefore to detect an effect of this size, where Power was 0.8, alpha was 0.5 and using a




A total of 54 people with MS gave consent for their name and contact information to be
passed to the lead researcher by their referrer. Of these people, four (7.41%) could not be
contacted; nine (16.67%) opted out prior to session one; eight (14.81%) participated in
session one but were excluded due to HADS scores above cut-off; two (3.70%) opted out
between sessions one and two; and one (1.85%) was excluded because she did not have a
diagnosis of MS. Therefore the experimental group consisted of 30 people who had MS
(henceforth, the MS group).
All 30 members of the MS group completed both tests of the FEEST, the Ekman 60
Faces and the Emotion Hexagon.
3.2 Demographic Characteristics: MS Group
3.2.1 Age; Years since diagnosis; HADS scores; and Predicted FSIQ
The female/male ratio within the MS group was 2:1; 20 females and 10 males. The data
describing the MS group's mean age, years since diagnosis, HADS scores, and NART
predicted WAIS-R Full Scale IQ (FSIQ) are presented in table 3.1.
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Table 3.1: Demographic summary data for the MS group
Mean SD Range (min-max)
Age 45.63 11.64 21-70
Years since diagnosis 12.40 9.17 1-31
HADS - anxiety 4.80 2.58 0-9
HADS - depression 3.33 2.22 0-9
NARTpredicted FSIQ 112.07 10.57 90-126
3.2.2 MS Sub-types
Relapsing/remitting MS was the most prevalent disease sub-type within the experimental
group (n = 15; 50%). Five participants (16.7%) reported having primary progressive MS
and five (16.7) reported having secondary progressive MS. A further three group
members reported having a progressive form of MS, but were not able to specify their
diagnosis further (n = 3; 10%). Two participants (6.7%) did not know their diagnosis.
Figure 3.1 summarises this data. The potential affects of gender, predicted FSIQ, and MS












Figure 3.1: Prevalence ofMS sub-types within the MS group (NOS — Not Otherwise
Specified).
3.3 Demographic Characteristics: Normative Data
The performance of the MS group was compared with normative data from the FEEST
(Young, Perrett et al, 2002).
3.3.1 Ekman 60 Faces Test
Ekman 60 Faces normative data were collected by the test authors from a sample of 227
healthy participants aged between 20 and 70 and with IQs of 90 and above. This sample
comprised 124 females (54.63%) and 103 males (45.37%). The authors completed a
three-factor ANOVA to establish how age, intelligence, and gender may affect test
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performance. They reported a borderline affect of age (F=2.39, (4, 190) p=.052) but no
other significant affects (ps >.1).
3.3.2 Emotion Hexagon Test
Emotion Hexagon normative data were collected by the test authors from a sample of 125
healthy participants, aged between 20 and 75, and with IQs of 90 and above. This sample
comprised 63 females (50.4%) and 62 males (49.6%). A three-factor ANOVA was again
completed to establish how age, intelligence, and gender may affect test performance.
No significant affects were found (ps>. 1).
3.4 Hypothesis (1): People with MS will be significantly worse at recognising
emotion from facial expression in comparison with normative data
This study hypothesised that people with MS would perform significantly worse on a test
of emotion recognition than would be predicted from normative data collected from a
healthy adult sample. Two techniques were employed to determine the validity of this
hypothesis:
(1): One-sample independent t-tests were completed to determine whether statistical
differences were present between the performance of the MS group and the published
normative data collected for the Ekman 60 Faces Test and the Emotion Hexagon Test.
Note that the effect sizes (ES) in this chapter have been calculated using a pooled
standard deviation (Coe, 2002). The effect sizes can be classified according to Cohen's
criteria (as reported in Cohen, 1992) where small = .20; medium = .50, and large = .80.
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(2) The FEEST cut-off scores were used to establish the number of MS group members
scoring within the impaired range (i.e. < 5th percentile).
3.4.1 The FEEST - Between-group comparisons
3.4.1.1 Ekman 60 Faces Test
The Ekman 60 Faces Test comprises a total of 70 items - one experimental trial of 60
items preceded by ten practice items. Each of the six emotions (anger, disgust, fear,
happiness, sadness, and surprise) is depicted ten times during the experimental trial.
Therefore the maximum score obtainable for each emotion is ten; the maximum total
score is 60.
Overall Scores
The mean overall Ekman 60 Faces score for the MS group was 45.03 (SD = 6.42),
whereas the normative data mean was 50.64 (SD = 5.04). There was a significant
difference between the two groups and a large effect size (t(29) = 4.784, /z<.001; ES =
1.1). This demonstrates that the MS group performed worse than the normative data in
recognising facial expressions on the Ekman 60 Faces Test, supporting the experimental
hypothesis that the MS group would be significantly worse at recognising emotion from
facial expression in comparison with normative data.
Scores for each emotion
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Figure 3.2 illustrates the differences between the MS group and the normative data on
recognition of individual emotions. Happiness was the emotion most easily recognised
by the MS group (M = 9.73, SD = .64) followed by surprise (M = 8.20, SD = 1.54), anger
and disgust (both M = 7.07, anger SD = 1.34; disgust SD = 2.55), sadness (M = 7.03, SD
= 1.99), and fear (M = 5.93, SD = 2.43). This is a different performance profile to the
normative group. Happiness was the most easily recognised (M = 9.87, SD = 0.42), then
disgust (M = 8.59, SD = 1.62), surprise (M = 8.55, SD = 1.44), sadness (M = 8.33, SD =
1.66), anger (M = 7.86, SD = 1.90), and fear (M = 7.19, SD = 2.03).
The MS group were significantly impaired compared with the normative data in
recognising four of the six emotions: anger (t(29) = 3.131, p = .004; ES = 0.4); disgust
(t(29) = 3.278, p = .003; ES = 0.8); fear (t(29) = 2.827, p = .008; ES = 0.6); and sadness
(/(29) = 3.567, p = .001; ES = 0.8). Differences between the groups in recognising
happiness and surprise were not statistically significant (p>.05). These results suggest







Figure 3.2: MS and normative group mean rates of recognition for the six different
emotions in the Ekman 60 Faces Test.
3.4.1.2 Emotion Hexagon Test
The Emotion Hexagon Test comprised a total of 180 items - five experimental trials of 30
items preceded by one practice trial of 30 items. These practice items and 30 other items
are not scored, and therefore the maximum total score on the Emotion Hexagon Test is
120. Each of the six emotions (anger, disgust, fear, happiness, sadness, and surprise) is
depicted four times in every one of the five experimental trials. Therefore the maximum
score obtainable for each emotion is 20.
Overall scores
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The mean overall score for the MS group was 102.17 (SD = 14.70), whereas the control
group mean was 107.97 (SD = 9.51). There was a significant difference between the two
groups with a medium effect size: (Z(29) = 2.163, p = .039; ES = 0.5). This demonstrates
that the MS group was significantly worse than the normative data on overall
performance on the Emotion Hexagon Test. It provides further support for the
experimental hypothesis that there would be a difference between the MS and control
groups on recognition of emotion from facial expression measured by the FEEST.
Scores for each emotion
Figure 3.3 illustrates the differences between the MS group and the normative data on
recognition of individual emotions. Happiness was again the emotion most easily
recognised by the MS group (M = 19.40, SD = 1.04). This was followed by sadness (M
= 18.63, SD = 2.01), surprise (M = 17.13, SD = 2.49), anger (M = 16.57, SD = 4.41),
disgust (M = 15.30, SD = 5.94), and fear (M = 15.13, SD = 5.30). This was in contrast to
the normative group who found happiness (M = 19.64, SD = .80) to be the most easily
recognised, then sadness (M = 18.38, SD = 3.42), disgust (M = 18.01, SD = 3.65), anger
(M = 17.84, SD = 2.80), surprise (M = 17.69, SD = 2.16), and fear (M = 16.56, SD =
3.76).
The MS group performed worse than the normative group on recognition of every
emotion apart from sadness. However, the discrepancies between the two groups were
less marked than on the Ekman 60 Faces Test. There was a significant difference
between the performance of the MS group and the control group on recognition of disgust
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(7(29) = 2.500, p=0.018; ES = 0.6). There were no other significant differences between






Figure 3.3: MS and normative group mean rates of recognition for the six different
emotions in the Emotion Hexagon Test.
3.4.2 The FEEST - Using cut-offs to classify performance
Many psychometric tests and questionnaires used in clinical and research practice
provide a cut-off score which indicates the boundary between impaired and non-impaired
performance. This is usually set at 1.65 standard deviations below the mean,
corresponding to performance at or below the 5th percentile for the population. The
FEEST manual provide cut-off scores for Ekman 60 Faces and Emotion Hexagon total
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scores as well as individual emotion recognition scores. A score at or below this cut-off
can be taken as indicating impaired performance on the test.
Assuming similar variance between groups, if it were the case that MS patients had more
difficulty in recognising emotions from facial expression, it might be expected that more
than 5% of the MS group would score within the impaired range (i.e. below the 5th
percentile). To support the experimental hypothesis that there would be a significant
difference between the MS and control groups in their ability to recognise emotion from
facial expression, significantly more than 5% of the MS sample should score at or below
the cut-off, thereby falling within the impaired range.
Using the cut-off scores for the Ekman 60 Faces and the Emotion Hexagon it was
possible to quantify the number of MS group participants scoring within the impaired
range for each of the six emotions and overall test performance. Binomial tests were
completed to determine whether the percentage falling within the impaired range was
significantly higher than the expected 5% of the normative sample.
3.4.2.1 Ekman 60 Faces Test
Table 3.2(a) shows the number and proportion of the MS group participants performing
within the impaired range on recognition of individual emotions and overall on the
Ekman 60 Faces test. Based on total test scores, significantly more members of the MS
group scored within the impaired range than the 5% that would be expected from the
normative data (p<.001). This was also true for recognition of disgust, fear, sadness,
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(/?s<.001), happiness, surprise (ps <.01) and anger (/?<.05). This suggests that deficits in
recognition of emotion from facial expression are more prevalent within MS than
neurologically healthy controls. Furthermore, the evidence shows that this impairment
affects recognition of all six emotions, rather than just the four negative emotions as
reported in section 3.4.1.
Table 3.2(a): Binomial comparison with normative data to show number & proportion of
MS group performing within the impaired range (at or below the 5th percentile) for
recognition ofeach emotion and overall on the Ekman 60 Faces Test





















.032 <.001 <.001 .006 <.001 .006 <.001
3.4.2.2 Emotion Hexagon Test
Table 3.2(b) shows the number and proportion of the MS group participants performing
within the impaired range on recognition of individual emotions and overall on the
Emotion Hexagon test. As with the Ekman 60 Faces, test the data collected from the
Emotion Hexagon test show that impaired recognition of emotion from facial expressions
is more prevalent in the MS group than the healthy normative sample. When using the
cut-off scores for comparison there were significantly more members of the MS group
scoring within the impaired range on overall test performance (p<.01) as well as
recognition of anger, disgust (ps<.01), fear, happiness, and surprise (ps <.05). There was
no difference between groups on prevalence of recognition of sadness (p>. 1).
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Table 3.2(b): Binomial comparison with normative data to show number & proportion of
MS group performing within the impaired range (at or below 5th percentile) for
recognition ofeach emotion and overall on the Emotion Hexagon Test





















.002 .006 .032 .032 1.108 .032 .002
3.5 Hypothesis (2): Impaired recognition of emotion from facial expression will
be correlated with impaired functional behaviour
This study also proposed the hypothesis that performance on the tests of emotion
recognition would correlate with reports of functional social impairment. Functional
social impairment was measured using the BAFQ, which collects information about
twelve domains of adaptive functioning. These twelve domains are: Planning, Initiation,
Flexibility, Excess Caution, Attention, Memory, Arousal, Emotionality, Impulse Control,
Aggressiveness, Social Monitoring, and Empathy. Information is collected from two
sources - the MS participant and a significant other (the informant). Therefore FEEST
performance can be correlated with both the self- and informant reports.
3.5.1 Everyday Adaptive Functioning
Each of the 30 MS group participants was asked to complete a self-report version of the
BAFQ and nominate a significant other to complete the informant version. Completed
questionnaires were returned by post. 24 (80%) completed copies of the BAFQ self-
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report were returned; 23 (76.7%) completed copies of the BAFQ informant report were
returned.
3.5.2 Associations between FEEST performance and BAFQ
To determine whether there were any relationships between adaptive functioning and the
ability to recognise emotion from facial expression, correlations were completed between
test performance on the FEEST and the self- and informant reports of the BAFQ. In
order to reduce the number of BAFQ variables and to maximise the relevance of the
analyses, only those scales relating to social behaviour were included. The five selected
sub-scales were: Emotionality, Impulsivity, Aggression, Social Monitoring, and
Empathy. Furthermore, it was assumed that only impaired emotion recognition would
have an affect on functional behaviour. Therefore the selected BAFQ sub-scale scores
were only correlated with those FEEST scores which were significantly different from
the normative data. As a large number of correlations were completed, only those with
p<.01 were considered to be statistically significant to reduce the risk of Type I errors.
Emotionality
There were no significant correlations between emotionality and recognition of emotion
from facial expression as measured by the FEEST (all ps >.01).
Impulsivity
There were no significant correlations between impulsivity and emotion recognition (all
ps >.01). However, the correlation between self-reports of impulsivity and recognition of
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disgust on the Emotion Hexagon (r= -.413, p = .044, two-tailed) was approaching
significance. For all remaining correlations p >.05.
Aggression
BAFQ informant reports of aggression were significantly correlated with recognition of
disgust on both the Ekman 60 Faces (r= -.618, p = .002, two-tailed), and the Emotion
Hexagon (r= -.617, p = .002, two-tailed). There were no other significant correlations
(all ps >.01).
SocialMonitoring
There were no significant correlations between social monitoring and emotion
recognition (all ps >.01). Correlations between informant reports of social monitoring
and recognition of disgust on the Ekman 60 Faces (r= -.435,p = .038, two-tailed), and
total Emotion Hexagon emotion recognition score (r= -.429, p = .042, two-tailed) were
approaching significance. For all remaining correlations p >.05.
Empathy
There were no significant correlations between empathy and emotion recognition (all ps
>.01)
In all cases the correlations were negative; thus decreases in recognition of emotion were
associated with greater difficulties in adaptive functioning. Correlation matrices
illustrating associations between the above sub-scales of the BAFQ (both self- and
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informant- reports) and all emotions that were significantly different from the norm can
be found in Appendix 5.
The use ofmultiple regression analyses was considered to investigate how impairment of
emotion recognition could predict functional behaviour. However, this was not pursued
as the MS group n was not of sufficient size. Field (2005) recommends 15 participants
for every predictor variable entered into the model. As recognition of four of the six
emotions was impaired on the Ekman 60 Faces test, an n of 60 would be necessary.
3.6 Hypothesis (3): Reports of MS participant's level of social functioning will
vary according to the information source - informants will report a significantly
greater number of deficits than the MS participants themselves.
All 68 items on the BAFQ are scored out of five. The scale scores for the twelve
domains of adaptive functioning are calculated by summing the scores for each scale and
dividing by the number of responses given. A high score represents a high level of













Figure 3.4: Mean self- and informant reports for the twelve sub-scales ofthe BAFQ
Figure 3.4 shows that both self and informant reports judged excess caution to be the
most problematic area, whereas impulsivity was the least. Generally, respondents did not
report the presence of many difficulties. However, there was some discrepancy between
self- and informant reports on several sub-scales. Statistical analysis was completed to
show whether these differences were significant.
Both the MS group participants and the informants were making judgements about the
same target (the MS participant), therefore repeated measures t-tests were completed in
order to analyse any differences between self- and informant-reports. To compensate for
the large number of comparisons completed (and hence the inflated likelihood of Type I
errors), alpha levels were set at 0.01, following the example of Hopkins et al (2002).
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There was a significant difference between self and informant reports of impulsivity
(7(22) = 3.422, p = .002;) and memory (t(22) = 2.921, p = .008). These findings were
opposite to the direction predicted by the hypothesis, with the MS participants reporting
greater impairment than the informants. No other significant differences were found
between self and informant reports (all ps >.01). All r-values are summarised in table
3.3.










Planning 1.91 (.68) 1.90 (.79) 0.214 .832
Initiation 1.98 (.82) 1.73 (.78) 1.456 .159
Flexibility 1.97 (.69) 2.11 (1.00) 0.488 .630
Excess Caution 2.88 (.72) 2.44 (.88) 2.130 .045
Attention 2.09 (.62) 1.79 (.84) 2.066 .051
Memory 2.05 (.63) 1.54 (.73) 2.921 .008
Arousal 2.28 (.70) 2.21 (.90) 0.563 .579
Emotionality 2.06 (.67) 1.74 (.76) 2.036 .054
Impulsivity 1.56 (.46) 1.26 (.31) 3.422 .002
Aggression 1.59 (.45) 1.45 (.67) 0.633 .533
Social Monitoring 2.03 (.53) 1.90 (.75) 0.878 .390
Empathy 1.54 (.63) 1.75 (.77) 1.269 .218
The presence of two group difference indicates that overall there was a high level of
agreement between the self and informant reports of the MS participant's functional
behaviour. This suggests that the members of the MS group had good insight into their
level of ability and this opinion was shared by their respective informants.
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3.7 Supplementary Analyses
3.7.1 Comparing performance on the Ekman 60 Faces and the Emotion Hexagon
The results suggest that there is a discrepancy between the MS group's performance on
the two tests of the FEEST. The Ekman 60 Faces produced a greater decrement in
performance between MS and normative data than the Emotion Hexagon. Specifically,
on the Ekman 60 Faces test the MS group were significantly worse at recognising four of
the six emotions (anger, disgust, fear, and sadness) and had a worse overall emotions
recognition score. In contrast, performance on the Emotion Hexagon test shows a
significant difference between the MS and control groups only on recognition of disgust
and overall emotion recognition scores. To explore further these observed differences in
performance between the two emotion recognition measures, scores on the measures
were converted to percentages. Paired t-tests were then completed to ascertain
differences between outcomes.
Two-tailed analyses showed that the MS group performed significantly worse on the
Ekman 60 Faces Test on recognition of anger (t(29) = 3.292, p = .003), fear (t(29) =
4.109, /?<.001), sadness (t(29) = 7.400, p<.001), and total score (/(29) = 7.843, pc.OOl)
than on the Emotion Hexagon. No other significant differences were found (all ps >.05).
The results are illustrated in figure 3.5.
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Figure 3.5: MS group mean % correct on the Ekman 60 Faces and Emotion Hexagon
Tests
As illustrated by figure 3.6, The Ekman 60 Faces and Emotion Hexagon Tests also varied
in the number of MS group participants they classified as impaired. Analysis showed
that the Ekman 60 Faces tests classified a significantly greater number ofMS participants
as impaired on recognition of sadness (x2 (1) = 10.42, p = .001). No other significant
differences were found (all />s>.05). These findings suggest that the Ekman 60 Faces
Test was the more difficult of the two FEEST tests. This contradicts reports that the
Emotion Hexagon Test is more sensitive to emotion recognition impairments due to the
increased ambiguity of the materials used (Calder et al, 2000). This finding also
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contradicts the reports of Young et al (2002) that the patterns of emotion recognition are
comparable between the two tests.
40
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Figure 3.6: Percentage ofMS group falling within the impaired range on the Ekman 60
Faces Test and the Emotion Hexagon Test.
3.7.2 Demographic characteristics and FEEST performance
Gender
The possibility of gender affecting performance on both tests of the FEEST was
investigated. The MS group was sub-divided by gender (female, n = 20; male, n = 10)
and the performance of both sub-groups compared using the Welch F test. No significant
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differences found between male and female participants on performance on either the
Ekman 60 Faces or Emotion Hexagon Tests (all ps >.05).
MS sub-type
As reported in section 3.2.2, within the MS group, relapsing/remitting MS was the most
prevalent disease sub-type (n = 15; 50%). Thirteen members of the group (43.4%) had a
progressive disease type. Therefore the MS group was sub-divided according to disease
type (relapsing/remitting or progressive) and their performance on the FEEST tests
compared using independent t-tests. The alpha level was again set at 0.01. No
significant differences were found between MS sub-types (all ps >.05).
Age
The FEEST authors noted a borderline affect of age on performance on the Ekman 60
Faces, but not the Emotion Hexagon. They defined three age categories: 20-40; 41-60;
61-70 (75 for the Emotion Hexagon). A similar comparison was completed here and
based on the existing literature it was predicted that increased age would be associated
with impaired recognition of emotion. The Young et al (2002) age categories were
adapted due to the relatively small sample size and reduced from three to two. The
categories were 20-45 (n = 15) and 46-70 (n = 15). No significant differences were found
between age groups (all ps >.05).
Correlation analysis, however, revealed a significant negative relationship between
participant age and recognition of anger (r = -.380; p - .038, two-tailed) and happiness (r
84
= -.379; p = .039, two-tailed) on the Ekman 60 Faces, and fear (r = -.367; p = .046) on the
Emotion Hexagon.
3.7.3 Attention, Fatigue, and Practise
Comparison between number of errors made on trials one and five of the Emotion
Hexagon was completed to investigate whether performance changed as time progressed.
It was hypothesised that a greater number of errors on trial one would provide evidence
to suggest that practise had a positive influence on performance. Alternatively, a greater
number of errors on trial five would provide evidence to suggest that attention or fatigue
had a negative influence on performance. No significant differences were found (p <.05).
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4 Discussion
The present study aimed to investigate the ability of people who have multiple sclerosis
to recognise emotion from facial expression. The study also aimed to determine how
ability to recognise emotion from facial expression affected functional behaviour. There
were three primary hypotheses under investigation, each of which shall be discussed in
relation to the results. This chapter also includes discussion of the supplementary
findings, implications for future research, and a critique of the methodology.
4.1 Hypothesis (1): People with MS will be significantly worse at recognising
emotion from facial expression in comparison with normative data.
To test this hypothesis, MS participants were assessed using the Facial Expression of
Emotion: Stimuli and Tests (FEEST, Young et al 2002), comprised of the Ekman 60
Faces and the Emotion Hexagon. The performance of the MS group was compared with
the published normative data, collected from neurologically healthy control participants.
Two techniques were used to determine whether there were significant between-group
differences. The first involved comparing mean performance scores of the two groups.
The second involved use of cut-off scores which helped to classify impairment within the
MS group.
4.1.1 Results Summary
Total emotion recognition scores
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The results supported the experimental hypothesis; there was a significant difference
between the performance of the MS group and the normative data. Overall, the MS
group performed significantly worse than would be expected based on normative data on
both of the FEEST measures of facial emotion recognition. Furthermore, when using the
cut-off scores to identify impairment, 36.67% of the sample fell within the impaired
range on the Ekman 60 Faces, and 23.33% on the Emotion Elexagon. This was
significantly different to the five per cent predicted to be impaired by the normative data.
The results therefore show that recognition of emotion from facial expression is more
likely to be impaired amongst individuals with MS and the impairment is of greater
prevalence compared to the normative data.
Recognition of individual emotions
Between-group comparisons showed that the MS patients had greater difficulty
recognising negative emotions (anger, fear, disgust, and sadness) than positive (happiness
and surprise). The magnitude of recognition impairment varied according to the FEEST
test used and by method of comparison. The MS group demonstrated greater impairment
on the Ekman 60 Faces test.
4.1.2 Comment
Previous studies
The results supported hypothesis (1) and also endorsed the earlier findings of Beatty and
Goodkin et al (1989) and Beatty and Orbelo et al (2003), that recognition of emotion is
impaired by multiple sclerosis. The results showed that emotional valence affected
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recognition: MS patients had greater difficulty recognising negative emotions (anger,
disgust, fear, and sadness). Beatty and Goodkin et al (1989) found no such affect of
valence in their study of facial emotion recognition. Nevertheless, the potential
functional outcome remains the same: difficulty recognising emotion could impair social
behaviour.
The present study also concurs with the findings of previous reports which have found
affect recognition to be impaired amongst neurological populations including TBI,
(McDonald and Flanagan, 2004; Green et al, 2004), lobectomy (Adolphs et al, 2001),
Huntington's disease (Sprengelmeyer et al, 1996), Parkinson's disease (Suzuki et al,
2006), Korsakov's syndrome and multi-infarct dementia (Crawford et al 1986).
Diffuse cerebral pathology and lesion location
It is possible that the observed deficits in emotion recognition reflect damage to cortical
and sub-cortical brain structures secondary to the disease process. The results may reflect
either: (1) diffuse cerebral pathology; and/or (2) damage to brain areas which are
fundamental to the recognition of facial emotion in others.
With regard to point (1), the lesions which characterise MS are typically widespread
throughout cortical and sub-cortical structures. These lesions produce a range of
symptoms, including cognitive impairments. It has been demonstrated that whole brain
atrophy and plaque burden within the cerebrum can lead to global cognitive impairment
(Bermel et al, 2002; Baumhefner et al, 1990). Furthermore, the presence of lesions
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within cerebral regions which are commonly affected by MS (e.g. the corpus callosum;
periventricular white matter and the third ventricle) can result in similar diffuse cognitive
impairments (e.g. Huber et al, 1992; Edwards et al, 2001; Pozzilli et al, 1991; Benedict et
al, 2002). Therefore the outcome of the present study could be due to diffuse cerebral
pathology causing diffuse cognitive impairments, including impaired ability to recognise
emotion from facial expression.
With regard to point (2), the observed results may be the consequence of lesions
inhibiting the operation of specific brain regions which are key to the recognition of
emotion. Areas including the temporoparietal lobe of the right-hemisphere, the limbic
system (the amygdala in particular) and the frontal lobes have all been implicated in
emotion processing. For example, Adolphs et al (2001) discovered that emotion
recognition was more impaired amongst patients who had undergone right-sided, rather
than left-sided, temporal lobectomy. Crawford et al (1986) implicated the limbic system
in impaired emotion recognition within certain dementia sub-types. Similarly Broks et
al, (1998) highlighted that damage to a specific component of the limbic system, the
amygdala, could impair emotion recognition. Therefore lesions within these areas, or
lesions limiting the activation of pathways to these areas, could account for the observed
impairment in facial emotion recognition found in the present study.
However, the remit of the present study was to investigate further a potential impairment
of MS which had hitherto received little research attention. Therefore the explanations
above are hypothetical as neuro-imaging data for the MS group were not gathered and
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detailed cognitive assessments were not completed (see section 4.5.1 for further
discussion).
4.2 Hypothesis (2): Impaired recognition of emotion from facial expression will
be correlated with impaired functional behaviour
The second experimental hypothesis was designed to investigate whether the ability to
recognise emotion from facial expression affected everyday functional behaviour. This
hypothesis was based on the assumption that the inability to identify emotion from non¬
verbal cues could lead to misinterpretation of an event's meaning, causing inappropriate
behavioural reactions, and potentially leading to difficulties in social interactions.
Everyday behaviour was assessed using the Brock Adaptive Functioning Questionnaire
(BAFQ). The BAFQ contains twelve sub-scales related to different aspects of functional
behaviour, including several sub-scales related specifically to social behaviour and social
functioning (emotionality, impulsivity, aggression, social monitoring, and empathy).
BAFQ data for each MS participant were collected from two sources: the participant
(who completed the self-report) and a significant other (who completed the informant
report).
4.2.1 Results summary
There was insufficient evidence to support hypothesis (2). With the alpha level set at .01,
few significant correlations were found between scores of emotion recognition on both
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FEEST tests and the self- and informant-reports of the BAFQ. However, some
correlations were approaching significance.
With regards to recognition of individual emotions, recognition of disgust was
significantly correlated with the BAFQ sub-scale of aggression. Disgust was correlated
with impulsivity, social monitoring, and empathy although these correlations fell short of
statistical significance. This trend could be interpreted, albeit cautiously, to suggest that
impaired recognition of disgust is more closely associated to functional social impairment
than the other five emotions. It also resonates with the findings of Sprengelmeyer et al
(1996), that people with Huntington's disease have particular difficulty recognising
disgust from facial expression.
4.2.2 Comment
There are a number of potential explanations as to why the present study found that there
were few difficulties of social behaviour amongst the MS sample, in spite of the observed
impairment of facial emotion recognition. Firstly, facial expression is a single, albeit
significant, non-verbal manifestation of emotion, whilst emotional states are typically
communicated by a variety of means, verbal and non-verbal alike. Therefore, the
reported absence of impaired social behaviour could be because other techniques of
recognising emotion remained relatively intact. Consequently, appropriate social
behaviour is not significantly affected.
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An alternative explanation relates to the BAFQ itself. It may be that the questions asked
were not representative of the problems experienced by the MS group or that the wording
of the questions was not specific enough. Therefore it may not have been sufficiently
sensitive to detect behavioural problems caused by impaired recognition of facial
emotion. Indeed, the BAFQ was originally designed to measure behavioural disturbances
manifested following traumatic brain injury affecting executive functions (e.g. Dywan
and Segalowitz, 1996) and not as a specific measure of social behaviour per se.
However, several of the sub-scales do relate specifically to social functioning.
There are currently no normative data yet available for the BAFQ. It is not therefore
possible to determine whether the reports of functional change from the MS group are
significantly worse than would be expected from a healthy population. It is also difficult
to conclude whether the difficulties recorded on the BAFQ are the consequence of a
range of problems rather than emotion recognition alone. However, the high level of
agreement between the self- and informant-reports suggests that the data gathered were a
reliable account of present impairment. Nevertheless, more reliability and validity data
are needed for the BAFQ and neurological populations, especially MS.
Finally, the BAFQ was a postal questionnaire and of the 30 copies distributed, only 24
self and 23 informant copies were returned. This had a consequent impact upon data
analysis. Also, it could be argued that those participants who did have more significant
social behaviour problems chose not to respond to the questionnaire or could not find a
suitable informant to complete the parallel form, thereby skewing the overall group data.
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4.3 Hypothesis (3): Reports of MS participant's level of social functioning will
vary according to the information source - informants will report a significantly
greater number of deficits than the MS participants themselves.
Overall there was a good level of agreement between the self- and informant reports.
There was a significant difference between self- and informant reports on impulsivity and
memory, and contrary to the hypothesis, these findings were due to the MS participants
reporting greater difficulty. Indeed this outcome appeared true of many of the BAFQ
sub-scales; there was a general trend for MS individuals themselves to report more
difficulties than their corresponding informants. Therefore the current data do not
support hypothesis (3).
4.3.1 Comment
The current findings were in contrast to the outcome of research investigating insight in
MS (e.g. Goverover et al, 2005; Beatty and Monson, 1991) and functional behaviour in
TBI measured using the BAFQ (Simpson and Schmitter-Edgecombe, 2002). Simpson
and Schmitter-Edgemcombe (2002) reported that self- and informant reports did not
significantly correlate within the sub-scales of emotionality, impulsivity, aggression, and
social monitoring. Informants rated a greater degree of impairment relative to the TBI
survivors which the authors interpreted as reduced insight into impairment of social
behaviours.
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The findings in relation to hypothesis (3) could be an artefact of the range of relationships
represented within the informants group. Parents, siblings, spouses, and friends all
contributed to the study. Some, e.g. those living with the person who has MS, would
arguably be more aware of everyday functional difficulties. Results could have been
different had there been strict guidelines as to who could act as informant.
4.4 Supplementary Comment
4.4.1 Performance discrepancy between Ekman 60 Faces and Emotion Hexagon
One unexpected finding of the study was the discrepancy between the MS group's
performance on the two FEEST tests. The Ekman 60 Faces test was created using the
Ekman and Friesen (1976) materials. The pictures feature expressions which are broadly
stereotypical and arguably not typical of natural emotions. The Emotion Hexagon was
designed to compensate for this. The materials were developed through the blending of
two original emotional expression photographs. This increased the ambiguity of the
expression as it contained characteristic features of two separate emotions. Hence, the
Emotion Hexagon was understood to be a more challenging task, more sensitive to
impaired emotion recognition than the Ekman 60 Faces Test (Calder et al, 2000).
The present study did not find evidence to support this. MS group participants performed
worse overall on the supposedly easier Ekman 60 Faces and were impaired on
recognition of four of the six emotions on the Ekman 60 Faces (anger, disgust, fear, and
sadness), compared to one (disgust) on the Emotion Hexagon.
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There are several possible reasons to account for this finding. Firstly, it could be the
consequence of the order in which the two tests were administered. The Ekman 60 Faces
was always administered first and so the reported finding could arguably be the result of
practise affects. However, although both tests follow similar principles and procedures,
both being tests of facial emotion recognition in which participants to judge photographs
of faces, the materials involved are quite different. The Emotion Hexagon uses
computer-modified photographs of one of the ten models from the Ekman 60 Faces. The
original pictures from which the modified materials are derived are not re-administered in
the Emotion Hexagon.
Furthermore, comparisons between the data collected from trials one and five of the
Emotion Hexagon suggest that practise did not have a significant affect on the FEEST
performance. If repeated exposure to the target materials increased accuracy of emotion
recognition, then the number of errors made in trial one should be greater than those
made in trial five. As reported in sections 3.6.3, no significant differences were found
between the error-frequency of these two trials.
Finally, the between-test discrepancies could be the consequence of increased familiarity
with the test procedure, rather than familiarity with test materials. In other words, Ekman
60 Faces performance could have been inhibited by temporary factors such as test
anxiety, motivation, or the novelty of testing which dissipated as the session wore on and




One of the reasons for the exclusion of potential participants was performance on the
HADS mood questionnaire that indicated possible mood disorder. This was introduced
into the screening procedure to control for the potential affects of moderate to severe
anxiety or depression on test performance. Mood had been demonstrated to be a factor
likely to influence emotion recognition (e.g. Mandal and Battacharya, 1985; Surguladze
et al, 2004) and is common in MS (e.g. Sadovnik, 1991). Therefore the benefit of using a
mood screen is that, in all probability, the demonstrated outcomes were independent of
mood. However, it is possible that inability to recognise emotion from facial expression
might play a causal role in the development of depression. Consequently some people
with emotion recognition problems may have been excluded from participating and thus
the current results may underestimate the extent of emotion recognition deficits in the MS
population.
Predicted intelligence
The mean intelligence of the MS group (as predicted by the NART) was 112, slightly
above average. It is likely that this figure is due to the exclusion of people with a
predicted 1Q below 90. It may also be evidence that high functioning people tend to be
more likely to volunteer for research. Both of these factors could have skewed the IQ
data set. The mean IQ of the normative sample is not known. However, it is likely that
the exclusion of people from the normative sample with IQ below 90 would have also
skewed the data set, causing the mean score to be above average.
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Gender and age
No significant affects of gender were noted. However it was found that recognition of
anger, happiness, (measured by the Ekman 60 Faces) and fear (measured by the Emotion
Hexagon) was affected by age. However, the correlations, although significant, were
modest and given that no significant correlations between age and emotion recognition
were found outwith those reported, it seems doubtful that age significantly affected the
results overall.
MS sub-type
The MS group represented a diverse range of MS sub-types, relapsing/remitting proving
to be the most prevalent. Certain presenting features are more commonly associated with
different disease sub-types. For example, cognitive impairment is more often associated
with progressive forms of the disease (e.g. Feinstein, Kartsounis et al, 1992; Beatty and
Goodkin et al, 1989). Beatty and Goodkin et al (1989) found relapsing/remitting MS
patients to be no different to healthy controls in their performance on tests of emotion
recognition. However, the present study found no affect of MS type on FEEST
performance. This observation could be accounted for by methodological differences.
Whereas the present study displayed each target photograph for a maximum of five
seconds, Beatty and Goodkin et al (1989) imposed no time limit. This implies that
people with MS struggle to process emotional information at speed, rather than fail to
recognise emotions per se.
97
4.5 Future Research
The area under investigation has received relatively little attention from researchers to
date. Therefore there are a number ofways in which the current findings can be explored
further in order to address in greater detail the association between MS and deficits in
emotion recognition.
4.5.1 Supplementary Assessment Measures
Cognitive assessment
It would be of value to determine which cognitive functions correlate with recognition of
emotion from facial expression. Cognitive assessment tests could be used to identify
whether impaired recognition of emotion is an isolated deficit or part of a cluster of other
cognitive difficulties. Cognitive assessment results could be used to investigate further
the suggestion that impaired recognition of emotion is secondary to global cognitive
impairment as a consequence of diffuse cerebral pathology (see section 4.1.2).
Test batteries such as the Wechsler Adult Intelligence Scales-Version III (WAIS-III,
Wechsler, 1997a) or the Repeatable Battery for the Assessment of Neuropsychological
Status (RBANS, Randolph, 1998) would be able to provide a general measure of global
cognitive functioning as well as information about individual cognitive skills. Further, it
would be valuable to identify whether impaired executive functioning, often associated
with behavioural dysregulation in social situations (see section 1.2.2.2), is related to
emotion recognition ability. Test batteries such as the Delis-Kaplan Executive Function
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System (D-KEFS, Delis, Kaplan, and Kramer, 2001) could be utilised to measure
executive impairment.
Physical assessment
The present study did not take a measure of physical impairment, in future studies it may
therefore useful to assess physical disability using, for example, the expanded disability
status scale (EDSS, Kurtzke, 1983). It would not necessarily be hypothesised that
physical impairment would be correlated with emotion recognition per se. However, the
EDSS, used in combination with a cognitive assessment could indicate level of disease
severity. This might then be used to predict likely performance on a test of emotion
recognition.
Mood assessment
There is scope to assess further how mood may affect FEEST performance. It would be
interesting to note if participants with scores above cut-offs on the HADS would perform
more poorly on emotion recognition measures. Two MS groups could be recruited, one
featuring people scoring below cut-off, one above, and comparison made between each
group's performance. Alternatively, correlation analyses would show if emotion
recognition abilities decreased as mood impairment increased. It would also be
interesting to conduct longitudinal studies which could help clarify whether emotional
recognition deficits lead to mood disorders or are a consequence of them.
Neuro-imaging data
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As mentioned in section 4.1.2, the observed results could be a consequence of general
cerebral atrophy or lesions present within key emotion-recognition centres of the brain.
Imaging data, such as that provided by MRI or CT scan, would help to clarify the
possible organic changes which may underlie impairment of emotion recognition. It
seems probable that impaired recognition of facial emotions will be related to the
presence of lesions within the cortical and sub-cortical areas responsible for emotion
recognition and/or areas of the brain with reciprocal connections to these areas. To test
this, two clinical groups could be recruited, one group who have lesions within the
emotion-processing areas of the brain, and one without. Each group's performance on
the FEEST could be compared to determine which group is most impaired, thereby
identifying possible neuroanatomical correlates more directly.
4.5.2 Associations Between the FEEST and Other Measures of Emotion Processing
People with MS may be impaired at recognising emotion from facial expression yet
capable of identifying emotion from other sources. Therefore it would be useful to
investigate their ability to make emotional judgements based on cues other than facial
expression and identify associations with FEEST performance. The Awareness of Social
Inference Test (TASIT, McDonald et al, 2002), for example, requires participants to
make inferences about a person's thoughts and intentions after watching them interact
with others on a video vignette. Further, Beatty and Orbelo et al (2003) used the
Aprosodia Battery to assess recognition of emotion from prosodic cues. If emotion
recognition is global, then one might expect impaired performance on the FEEST to
accompany impaired performance on the Aprosodia Battery or the TASIT.
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It would be valuable to determine whether impaired recognition of emotion, either from
facial expression or other sources, is a stand-alone problem or part of a cluster of other
impairments of emotion processing. Problems such as emotion regulation and emotional
blunting may accompany impaired recognition of emotion.
4.5.3 Assessment of Social Functioning
As mentioned above, the BAFQ may not have been sufficiently sensitive to the social
functioning of the current sample. Future research could therefore make use of another
measure of social functioning or a modified version of the BAFQ to include additional
items concerning social activity, relationships in particular. Number of close friends,
frequency of social visits made, and relationship quality could all be informative.
With regard the BAFQ specifically, future research could investigate discrepancies
between the reports of informants on the BAFQ, as mentioned in section 4.3.2. It is
plausible that informants who live in the same household as the study participant will
have a more informed opinion about their functional behaviour relative to a friend or
relative who has less frequent contact. If this is demonstrated to be the case then perhaps
more stringent guidelines would be needed to inform who constitutes a significant other
capable of completing the BAFQ and other such measures.
4.6 Implications for Clinical Practice
101
The primary motive of this research project was to investigate the social cognitive
abilities of people who have MS, specifically their ability to perceive the emotional states
of others. This was thought to be valuable given the likely detrimental consequences of
impaired recognition of emotion. The reduced ability to recognise emotion in others has
the potential to disturb social relationships because it would inhibit the likelihood of
making an appropriate behavioural response. This could be misinterpreted as being, for
example, unsympathetic and make the relationship less rewarding. Therefore someone
who cannot recognise how others are feeling is at greater risk of becoming increasingly
socially isolated, which would almost certainly place them at increased risk of mental
health problems. Arguably the most important relationship for someone who has MS,
particularly as disease severity increases, is with their carer. Deterioration in the quality
of this relationship has potentially harmful consequences for both parties.
Therefore, one of the benefits of this project has been to highlight the existence of a
difficulty which had hitherto received little research attention and yet has the potential to
significantly affect the social relationships of people who have MS. Additional research
will be necessary before clinical implications can be more clearly defined. However, on
current evidence it seems that assessment of emotion recognition abilities could be
introduced into the battery of tests ordinarily used to assess cognitive functioning in MS
and consideration of social functioning should be included within psychological
assessment. Also, increased awareness of this problem amongst people with MS, their
carers, friends, and family could help them to prepare for potential changes in this area.
102
4.7 Critique - Project Strengths and Limitations
4.7.1. MS Group Recruitment
Recruitment to the MS group was informed by strict inclusion and exclusion criteria.
This was to help control for a number of factors which had the potential to confound the
outcome. These included age, intellectual functioning, mood, history of neurological
dysfunction outwith MS, and visual perception. Care was also taken to exclude potential
participants who had difficulties which could have inhibited their ability to complete the
primary outcome measure, the FEEST. Therefore potential participants with expressive
language or visual impairments were not included within the experimental group.
These stringent inclusion criteria reduced the number of participants eligible for inclusion
but helped increase confidence that the results reported were the consequence of key
variables of interest in the study rather than other potentially confounding factors. Visual
impairment was controlled for using the Shape Detection Test and the NART was
included both to provide a general measure of intellectual functioning, and to help attain
parity with the FEEST normative data. Arguably inclusion of a cognitive assessment
would also have been valuable and indeed was considered as part of the screening
procedure. However, addressing the associations between FEEST performance and
specific aspects of cognitive functioning was beyond the remit of the current study.
Furthermore, use of a cognitive screen to inform inclusion criteria would have possibly
facilitated recruitment of an atypical MS sample that was not representative of the MS
population.
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Recruitment was not limited to one MS sub-type and consequently the observed results
could arguably have been caused by the performance of one MS sub-type. However,
aside from further limiting the population from which the experimental sample was
selected, the validity of focusing attention on a single sub-type is doubtful. Not everyone
with MS has a definitive diagnosis and diagnosis can change from one type to another.
What is more and as previously reported, there can be considerable variance within sub¬
type. The decision to be inclusive in recruitment to the experimental group was justified
on data analysis when sub-type was not found to affect performance on the FEEST.
4.7.2 Normative Data vs. Control Group
The study's primary aim, to assess whether MS impaired recognition of emotion from
facial expression, was investigated through comparison of an MS groups' performance on
a test of facial emotion recognition with that of a neurologically healthy sample. The
assessment used, the FEEST, has normative data collected from a large sample of
neurologically healthy adults. These norms were used in place of a control group and
judgements about relative impairments of emotion recognition in MS were made using
them.
Recruitment of a demographically-matched clinical group could have helped inform
conclusions about the results. A neurological sample could have provided information on
the relative magnitude of the deficit in MS, whilst inclusion of a neurologically well but
physically disabled group (e.g. spinal injury patients) would have helped to control for
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additional factors such as physical functioning. However, the study was concerned
exclusively with the affects ofMS on emotion recognition and inclusion of extra clinical
groups would have reduced the numbers of MS patients that could have been recruited
and assessed within the time-frame of the study.
4.7.3 Experimental Measures
The Facial Expression ofEmotion; Stimuli and Tests (FEEST)
The FEEST was selected as the outcome measure for the primary research hypothesis for
several reasons. It is founded upon the long-established research of Ekman and Friesen
(1976), investigating the recognition of emotion from facial expression. Both of its
constituent tests have been demonstrated to be valid and reliable measures of facial
emotion recognition (e.g. Young, Perrett et al, 2002; Calder et al 2000b; Keane et al,
2002; Sprengelmeyer et al, 1999). Administration is straightforward; completion is
neither time-consuming nor reliant upon functional motor control.
Although cognitively undemanding, the participant is required to focus and sustain
attention for the duration of the test. Completion also requires participants to maintain an
adequate level of arousal and wakefulness. MS has been found to affect focused,
divided, and sustained attention (e.g. De Sonneville et al, 2002; Rao, Leo, Bernardin et
al, 1991). Fatigue, a common physical symptom of MS (Fisk et al, 1994), is believed to
compromise cognitive functioning (Schwartz, Coulthard-Morris and Zeng, 1996). The
FEEST helps to compensate for the potential confounding affects of fatigue and attention
impairment through availability of breaks during completion.
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The potential affects of attention and fatigue were also addressed during data analysis. If
attention or fatigue had a significant affect on FEEST performance, it was hypothesised
that there would be significantly more errors on trial five of the Emotion Flexagon than
on trial one. Comparison of these two data sets showed no such differences. It therefore
seems unlikely that attention or fatigue played a significant role in the observed results.
There is currently no published research using the FEEST with the MS population and
therefore its application here is helping to further the existing literature on emotion
recognition in MS. This does however make it difficult to evaluate the results more
thoroughly as there is no existing point of reference within the MS population with which
to compare the findings. Also the cut-off scores used to classify impairment were
arguably overly stringent in classifying impairment in recognising certain individual
emotions. For example on the Ekman 60 Faces a respondent was classified as impaired
at recognising happiness if they scored below 100% as the normative data uniformly
scored at ceiling levels. Therefore, making only one error in recognising a happy face
due to a lapse in concentration or other extraneous error could have resulted in 'impaired'
performance within that emotion category.
The BrockAdaptive Functioning Questionnaire (BAFQ)
The secondary aim of the present study was to ascertain whether impaired recognition of
emotion from facial expression was associated with social behaviour. The BAFQ was
selected as the assessment tool because it provides subjective information from two
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sources, the MS participant and a significant other. This was advantageous as it helped to
compensate for potential inaccuracies caused by insight deficits, positive response bias,
and under- or over-estimates of functioning.
However, for reasons discussed in section 4.2.2, above, the BAFQ may have limitations
as an outcome measure for the given area of investigation. An adapted version of the
BAFQ or a new questionnaire may have been preferable, but such measures would lack
the reliability and validity data available for the BAFQ.
4.8 Summary
This research project sought to investigate whether recognition of emotion from facial
expression was impaired in multiple sclerosis. This was thought valuable given that
impaired comprehension of the emotional states of others could have a damaging affect
on social relationships. This could in turn have a detrimental effect on the emotional
well-being of people with MS, their ability to maintain close relationships, friendships,
and function effectively in occupational or recreational settings.
MS participants were assessed using the two tests of emotion recognition in the FEEST,
the Ekman 60 Faces and the Emotion Hexagon. The performance of the MS group was
compared to the normative data available for neurologically healthy adults on the FEEST.
It was discovered that, relative to the normative data, the MS group were impaired overall
at recognising emotions. They were also impaired at recognising individual emotions,
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particularly anger, disgust, fear, and sadness. Performance varied between the two tests
used, with the Ekman 60 Faces identifying a greater level of impairment.
The remit of the present study was to investigate further a potential impairment of MS
which had hitherto received little research attention. As such, neuro-imaging data were
not gathered. Therefore it has not been possible to conclude with any certainty whether
the observed results have been due to discrete or more diffuse cerebral pathologies.
The research project also aimed to investigate whether impaired recognition of
impairment had an affect on social behaviour. This was assessed using the BAFQ, a self-
report questionnaire completed by the MS participant and a significant other. Impaired
overall recognition of emotion, as measured by the FEEST, was not found to be
significantly related to any of the BAFQ sub-scales. Also, it was significant to note that
the mean scores on the BAFQ were generally low. This suggests either that the
behaviours investigated by the BAFQ were not problematic for the MS group or that the
BAFQ was not sufficiently specific or sensitive enough to measure salient social and
emotional factors underlying observed functional behaviour. Furthermore, the BAFQ
self and informant reports were very similar, indicating good agreement between the two
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Brock Adaptive Functioning Questionnaire (BAFQ)
• Self-report
• Informant report (female participant)
THE BROCK ADAPTIVE FUNCTIONING QUESTIONNAIRE
(Self-report)
Name: Current Date:
The information you provide will help us understand how changes in your abilities may be affecting your
day to day function. These changes for some people may be so minor as to be unnoticeable but for some
people they may be quite severe. So, some of these questions may seem inappropriate with respect to
you but they are in the questionnaire to allow for all levels of severity. Simply read each question
carefully and indicate as best you can how well the question reflects your everyday functioning by
checking the appropriate space underneath each question.
If you cannot answer a question, circle the [ ? ] at the right of the page.
If you feel that you would have answered a question the same prior to your current difficulties, place a
check beside same which means that this aspect ofyour behaviour has not changed.
Ifyour response is different than it would have been before your current difficulties, place a check beside
changedwhich means that there has been a change in this aspect ofbehaviour. Change usually refers
to some decline in function. However, ifthe change has been for the better, indicate this with a plus
sign (+) beside that question.
Please note:
If, for any reason, you are unable to complete this questionnaire without assistance, we ask that
you get assistance from a person other than the family member completing the other packet of
questionnaires. We also ask that the individual assisting you not try to influence your answers in
any way.
8 Jane Dywan, Ph.D., 1994(version 04BClinical; 2002)
Place a circle the number that best describes your behaviour. Read your choices carefully each time so
you check the right end of the scale. Some behaviours may never be true of you. If you like, you can
write "never" where we say "hardly ever" and then check that place.
1. Do you have a hard time making plans for the day on your own?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
2. When going out for the day, do you think about what might be needed later in the day,
for example, bringing a jacket in case it gets colder?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ]changed
3. When you have several tasks to do, do you organize them in an efficient way?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
4. Would you be able to manage (take the appropriate steps) if an emergency came up
and you were home alone?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ]changed
5. When making choices, do you consider how these choices may affect you in the future?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
6. When making long term plans, do you think carefully about what you would need to
do in order to reach your goals?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
7. When you makes plans, would you say that your plans show good judgement ?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
8. Are you able to get up on time in the morning without actually being prompted
by another person?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
9. Do you carry out your household jobs without being reminded by anyone?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
10. Do you have trouble getting started on a project unless someone starts you off?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
11. Even though you know exactly what has to be done to keep a project going, do you have
a hard time moving to the next step on your own?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
12. Once you have made plans, do you find it very difficult to change them?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
13. When doing a task, can you easily distinguish between the more important and the less
important aspects of the task. (Would you be able to skip the less important steps?)
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
14. When telling someone about an event or a movie, can you easily skip unimportant details
pressed for time?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
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4 5 [ ] same
[ ]changed
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[ ] same
[ ] changed
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46. Do you use alcohol (or other drugs) more than you should?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed







Often Almost always [ ? ]
4 5 [ ] same
[ ] changed









Almost always [ ? ]
5 [ ] same
[ ] changed
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4 5 [ ] same
[ ] changed







Often Almost always [ ? ]
4 5 [ ] same
[ ]changed
51. Do you need external constraints in order to control eating (for example, careful control over







Often Almost always [ ? ]
4 5 [ ] same
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Often Almost always [ ? ]
4 5 [ ] same
[ ] changed
54. When you get angry, will you threaten people?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ]changed
55. If pushed to the limit, could you strike out at someone?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
56. Would you do what you really want to do, even if it were illegal?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
j ] changed
57. Do you stand a little too close when engaged in a conversation?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
| ] changed
58. Do you miss the point ofmany jokes or stories that other people seem to enjoy?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
} ] changed
59. Do you pay attention to whether others are following what you are saying?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
60. When you are telling things to other people, do you give them as much background
information as is needed so they can follow easily?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ]changed
61. If others are looking disinterested in what you are saying, will you try to stop talking or change
the topic?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
62. Do you tend to tell the same story over again to the same people?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
63. When a social situation has gone badly, do you try to figure out what went wrong so you can
make it go better the next time?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ]changed
64. If you had just received a favour or some special consideration, would you show appropriate
appreciation?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
65. Would you notice if someone were feeling overtired or worried?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ]changed
66. If you noticed that someone close looked overworked or worried, would you do what you could
to ease their load?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
67. Do you notice when other people are feeling awkward in a social situation?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
1 2 3 4 5 [ ] same
[ ] changed
68. When someone is feeling awkward in a social situation, will you do what you can to make the
person feel more comfortable?
Hardly Ever Rarely Sometimes Often Almost always [ ? ]
I 2 3 4 5 [ ] same
[ ] changed
Please indicate, by putting a mark through the following line, how satisfied you are with your life:
Completely Not at all
Satisfied Satisfied
Thank you.
THE BROCK ADAPTIVE FUNCTIONING QUESTIONNAIRE
(Version for Family Member of Person with Injury)
Name ofperson who has had injury:
Name of respondent:
We are asking you to fill out this questionnaire to provide another perspective on any difficulties your
family member might be having as a result of her accident or injuries. In order to maintain this alternate
perspective, it is important that you fill out this questionnaire without consulting with your family
member. When you are done, and the questionnaire has been returned, you are perfectly free to discuss
your responses if you wish.
The information you provide will help us understand the long-term effects of injury. These effects may
be so minor as to be unnoticeable for some people but they may be very severe for others. So, some of
these questions may seem inappropriate with respect to the person you are rating, but they are in the
questionnaire to allow for all levels of severity.
Simply read each question carefully and indicate as best you can how well the question reflects the
everyday functioning ofyour family member by checking the appropriate space underneath each
question.
If you cannot answer a question, circle the [ ? ] at the right of the page.
If you feel that you would have answered a question the same before your family member had her injury,
place a check beside same which means that this aspect of her behaviour is the same as before her
injury.
If your response is different than it would have been before the injury, place a check beside changed
which means that there has been a change in this aspect ofbehaviour thatyou have noticed since her
injury.
All information will be treated with strictest confidentiality. Names will be changed to codes and
combined with the data from others. Thus, if these data are published or used for teaching purposes,
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-ace a circle the number that best describes your family member's behaviour. Read your choices carefully each time
you check the right end of the scale. Some behaviours may never be true of your family member. If you like, you
-n write "never" where we say "hardly ever" and then circle the number.
Does she have a hard time making plans for the day on her own?
Hardly Rarely Sometimes Often Almost always [?]
Ever [ ] same
1 2 3 4 5 [ ] changed
When going out for the day, does she think about what might be needed later in the day, for example,
bringing a jacket in case it gets colder?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
] changed
When she has several tasks to do, does she organize them in an efficient way?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ]changed
Would she be able to manage (take the appropriate steps) if an emergency came up and she were home
alone?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ]changed
When making choices, does she consider how these choices may affect her in the future?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
When making long term plans, does she think carefully about what she would need to do in order to
reach her goals?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
2
When she makes plans, would you say that her plans show good judgement (i.e., are they realistic?)
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
Is she able to get up on time in the morning without actually being prompted by another person?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
Does she carry out her household jobs without being reminded by anyone?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
f 1 changed
3. Does she have trouble getting started on a project unless someone starts her off?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
j ]changed
1. Even though she knows exactly what has to be done to keep a project going, does she have a hard time
moving to the next step on her own?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
Once she has made plans, does she find it very difficult to change them?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ 1 changed
1 2 3 4 5
3. When doing a task, can she easily distinguish between the more important and the less important
aspects of the task (That is, if forced to hurry, would she be able to skip the less important steps?)
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
| ]changed
3
I. When telling someone about an event or a movie, can she easily skip unimportant details if pressed for
time?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
f ] changed
1 2 3 4 5
Does she have a hard time switching topics during a conversation?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
5. Does she appear to go over and over the same things in her mind more than she need to?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
7. Does she like to do things in the same way each time?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
8. Does she become uncomfortable if her usual routines have to be changed?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
| ] changed
1 2 3 4 5
Does she check manv times to make sure that things are safe (e.g. doors locked, stove off etc.)?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed
1 2 3 4 5
3. Does she seem more suspicious of other people than you think is necessary?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
f ]changed
4
1. Does she get distracted easily?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed
1 2 3 4 5
Is she likely to forget that the stove or kettle has been left on?
Hardly
Ever
Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed1 2 3 4 5
3. Does she have a lot trouble keeping track ofwhere things are around the house?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ]changed
4. Does she have trouble following spoken directions?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
] changed
5. Does she have trouble sticking to the point that she is trying to make when having a discussion?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
j ] changed
1 2 3 4 5
Is she easily confused in stores and shopping malls?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
| 1 changed
1 2 3 4 5
7. Is she likely to get lost even in relatively familiar places?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
| 1 changed
:8. Does she have a hard time learning new skills?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
1 ]changed
1 2 3 4 5
5
■9. Does she have difficulty remembering events that happened in the last week?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
Does she have difficulty remembering to do things that she has planned to do?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ 1 changed
Does she have trouble remembering the names of people that she sees regularly?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ]changed
Does she have a hard time recognizing people she has met before?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
Does she have trouble recalling things that she used to know quite well?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ 1changed
Does she tell people things that may not be true?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
f ]changed
15. Does she tell people things that could not possibly be true?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ 1 changed
6
5. Does she have difficulty staying awake or alert?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
\ 1 changed
1 2 3 4 5
Does her voice sound flat compared to other people?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
| 1 changed
1 2 3 4 5
8. Does she find it very difficult to get enthusiastic about things?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ]changed
9. Does she find it very hard to maintain interest in what she is doing for a long period of time?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
■0. Does she seem very sad or depressed?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
Does she get much too excited about things?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
j ]changed
1 2 3 4 5
2. Does she have difficulty controlling emotional responses (e.g., crying much too easily)?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
| ]changed
7
"3. Are there times when she laughs or talks too much or too loudly compared to others?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
| ] changed
1 2 3 4 5
Do you find that her eye contact can be too intense during conversations?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
1 changed
1 2 3 4 5
5. Does she make inappropriate comments or blurt things out that would be better left unsaid?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
6. Does she use alcohol (or other drugs) more than she should?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
Does she spend money unnecessarily without giving it much thought?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
1 changed
1 2 3 4 5
■8. Does she make sexual remarks which seem inappropriate?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
S ]changed
19. Does she touch people in ways which are sexually inappropriate?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
| ]changed
8
0. Does she have a lot of trouble controlling the amount she eats?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
1. Does she need external constraints in order to control eating (for example, careful control over what
food is left around the house or a lock on the refrigerator)?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
I ]changed
2. Is she quick to take offence to what others say?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed
1 2 3 4 5
13. When she gets frustrated, will she throw things around or damage things?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
A. When she gets angry,will she threaten people?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
f 1 changed
1 2 3 4 5
If pushed to the limit, could she strike out at someone?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed
1 2 3 4 5
56. Would she do what she really wants to do, even if it were illegal?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ 1 changed
1 2 3 4 5
9
17. Does she stand a little too close when engaged in a conversation?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
f 1 changed
1 2 3 4 5
Does she seem to miss the point ofmany jokes or stories that other people seem to enjoy?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ 1 changed
1 2 3 4 5
59. Does she seem to pay attention to whether others are following what she is saying?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ]changed
1 2 3 4 5
■50. When she is telling things to other people, does she give them as much background information as is
needed so they can follow easily?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
[ ] changed
61. If others are looking disinterested in what she is saying, will she try to stop talking or change the topic?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
f 1 changed
1 2 3 4 5
Does she tend to tell the same story over again to the same people?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
| ]changed
1 2 3 4 5
63. When a social situation has gone badly, does she try to figure out what went wrong so she can make it
go better the next time?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
j ]changed
10
>4. If she had just received a favour or some special consideration, would she show appropriate
appreciation?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed
1 2 3 4 5
Would she notice if someone was feeling overtired or worried?
Hardly Ever Rarely Sometimes Often Almost always [?]
[ ] same
[ ] changed
1 2 3 4 5
>6. If she noticed that someone close looked overworked or worried, would she do what she could to ease
their load?
Hardly Ever Rarely Sometimes Often Almost always m
1 2 3 4 5 [ ] same
| ] changed
37. Does she seem to notice when other people are feeling awkward in a social situation?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
| 1 changed
68. When someone is feeling awkward in a social situation, will she do what she can to make the person
feel more comfortable?
Hardly Ever Rarely Sometimes Often Almost always [?]
1 2 3 4 5 [ ] same
f ] changed
Axe there any areas in everyday functioning which have changed since the onset of her difficulties that have not been




Participant Information Sheet & Consent Forms
Research Participant Information Sheet - Version 2, March 2006
Project Title: Acquired Deficits in the Recognition of Facial Emotion in People who
have Multiple Sclerosis (MS).
Invitation
You are being invited to take part in a research study. Before you decide it is important
for you to understand why the research is being done and what it will involve. Please
take time to read the following information carefully and discuss it with others if you
wish. Ask us if there is anything that is not clear or if you would like more information.
Take time to decide whether or not you wish to take part.
Thank you for reading this.
What is the purpose of the study?
A small number of studies have shown that some people who have MS have difficulty
correctly identifying the emotions of others. This could potentially lead to problems in
everyday social relationships.
This study aims to investigate this area further and develop the existing findings. It
makes use of new tools to assess emotion recognition. These tools have not previously
been used with an MS population. The study also gives the participant the chance to
report any social problems that they may have. The study will run from spring 2006 until
summer 2007.
It is hoped that the findings will contribute to a growing understanding of the difficulties
faced in MS. The findings could help to inform future support and treatment initiatives.
Why have I been chosen?
This study is only being carried out in Lothian and someone who is involved in your
healthcare (for example Consultant Neurologist, MS Nurse Specialist, Occupational
Therapist) has identified you as a potential participant.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will
be given this information sheet to keep and be asked to sign a consent form. If you decide
to take part you are still free to withdraw at any time and without giving a reason. A
decision to withdraw at any time, or a decision not to take part, will not affect the
standard of care you receive.
What will happen to me if I take part?
You will be invited to come along to a maximum of two sessions. The first one will
involve completing a number of 'paper-and-pen' assessments including questionnaires.
You may then be asked to take part in a second appointment scheduled for a later date.
During this session you will be asked to complete a computer-based assessment and a
questionnaire. You will also be asked to nominate someone who can complete a similar
questionnaire about you. This should be someone who knows you well and could include
your partner, family member or a friend. This person does not need to be present for
either of the sessions as the questionnaire can be posted to them and be completed at
home.
Both assessment sessions should last no more than 60 minutes. The sessions will take
place either at the Neuropsychology Department, Astley Ainslie Hospital, Western
General Hospital, Liberton Hospital or your home. Where the sessions take place will be
up to you.
What do I do once I've made my decision?
The departmental secretary will phone you a week after you have received this form and
you can tell her if you want to take part. If you agree to take part then I will phone you to
introduce myself and to arrange an initial appointment.
Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will be
kept strictly confidential. Any information about you will have your name and address
removed so that you cannot be recognised from it. Your GP will be contacted and told
that you will be taking part in the study. However, details of the outcome of the sessions
will be kept confidential.
What will happen to the results of the research study?
The results of the study will be reported in the Lead Researcher's doctoral thesis. The
thesis is being written as part of training to become a Clinical Psychologist. Once it is
completed a copy will be available from the University of Edinburgh library. People who
take part in the study will not be identified in the thesis.
Who has reviewed the study?
The study has been reviewed and approved by the Lothian Research Ethics Committee.
Contact for Further Information
If you have any questions, or if you would like further information, then please feel free
to get in touch with me using the contact details on the letterhead.






Consent Form for Participant
Title of Project: Acquired deficits in the recognition of facial emotion in people who have
Multiple Sclerosis




I confirm that I have read and understood the information sheet dated
(version .) for the study named above and I have had the opportunity to ask
questions.
I understand that my participation is voluntary and that I am free to withdraw at
any time without giving any reason and without my medical or legal rights being
affected.
I understand that sections of my medical notes may be looked at by responsible
individuals from the Department of Neuropsychology. I give permission for these
individuals to have access to my records.
I understand that this is part of a research project designed to promote
psychological knowledge and which may be of no benefit to me personally
5 I agree to take part in the above study
Name of Participant Date Signature
Name of person taking consent Date Signature




Consent Form for Companion
Title of Project: Acquired deficits in the recognition of facial emotion in people who have
Multiple Sclerosis




I confirm that I have read and understood the information sheet dated
(version .) for the study named above and I have had the opportunity to ask
questions.
I understand that my participation is voluntary and that I am free to withdraw at
any time without giving any reason and without my medical or legal rights being
affected.
I understand that this is part of a research project designed to promote
psychological knowledge and which may be of no benefit to me personally
4 I agree to take part in the above study
Name of Participant Date Signature
Name of person taking consent Date Signature
(if different from researcher)
Researcher Date Signature
Appendix 3







Telephone 01 31 536 9000








Telephone: 0131 536 9061
Facsimile: 0131 536 9346
20 March 2006




Department of Clinical Psychology
133 Grange Loan, Edinburgh
EH92HL
Dear MrWarwick
Full title of study:
REC reference number:
Acquired deficits in the recognition of facial emotion in
people who have Multiple Sclerosis
06/S1101/6
Thank you for your letter of 13 March 2006, responding to the Committee's request for
further information on the above research and submitting revised documentation.
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the
above research on the basis described in the application form, protocol and supporting
documentation as revised.
Ethical review of research sites
The favourable opinion applies to the research sites listed on the attached form.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the
attached document. You are advised to study the conditions carefuliy.
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document Version Date
Application 2 13 March 2006
Investigator CV CI 03 February 2006
Investigator CV Supervisor 03 February 2006
Protocol 1 03 October 2005
Cpvfring Letter 03 January 2006




GP/Consultant Information Sheets 1
Participant Information Sheet 2 13 March 2006
Participant Information Sheet 1 Significant
Other
13 March 2006
Participant Consent Form 2 13 March 2006
Participant Consent Form 1 Significant
Other
13 March 2006
Response to Request for Further Information 13 March 2006
Research governance approval
The study should not commence at any NHS site until the local Principal Investigator has
obtained final research governance approval from the R&D Department for the relevant NHS
care organisation.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for
Research Ethics Committees (July 2001) and complies fully with the Standard Operating
Procedures for Research Ethics Committees in the UK.
06/S1101/6 Please quote this number on all correspondence





Standard approval conditions [SL-AC1 for CTIMPs, SL-AC2 for other
studies]
Site approval form
Copy to: University of Edinburgh
Department of Clinical and Health Psychology,
School of Health in Social Science, University of Edinburgh,
Medical School, Teviot Place
[R&D Department for NHS care organisation at lead site]
SF1 list of approved sites
06/S1101/6
Page1
Lothianc lResearchEt csC mmittee01
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Forallstudiesrequiringsi e-specificassessment,thiformis dbyma nRECCh fInv tigatornponsw tha o rabli iole d followingsubseque tnotificatio sr mtas ss rs.Fis u2on a ds,lls tewi hfav ur blepin nli t ,ddi gth wsp ov d. RECreferencenumber:06/S1101/6Issuu ber:1Datofi2Ma ch006 ChiefInvestigator:MrRoss,KWarwick Fulltitleofstudy:Acq ireddeficitsinthrecognitionfa almot onpe plewhhavM t pS l r s Thisstudywagivenafavourableethicalpinionbytv cec irffLot acRese rchEth sC mm tt0120M h006.f l opinionisextendedt achfheit slis db low.Thresearchm ycommencetNFISitwhanagementa provalfrrel v tHc organisationhbeenconfirmed. PrincipalInvestigator MrRossKWarwickPost TraineeClinical PsychologistResearchiteSiteassessor LothianPrimaryCarec lResearch NHSTrust(AstleyAinsliEthicsCommi te01 Hospital/Liberton Hospital)Lothian UniversityHospitalNHS Trust(WesternGeneral Hospital) ApprovedbythC aironehalffREC: (SignatureoPeh ir/Administrator) (deleteaspplicable)
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Appendix 4
FEEST materials
4(a): Ekman 60 Faces
4(b) Emotion Hexagon
4(a) - Ekman 60 Faces Materials (Young et al, 2002)
P F2 F4 F5 F6 F7 F8 M1 M4 M5 M6
The column labelled 'P' denotes the practice items. All other columns represent the experimental
items and are labelled by model identifier. Rows are labelled according to the six emotions: anger (A);
disgust (D), fear (F), happiness (H), sadness (S), and surprise (U).
4(b) - Emotion Hexagon Test Materials (Young et al, 2002)
90:10 70:30 50:50 30:70 10:90
Columns are labelled according to the degree by which two emotions are mixed together. The rows are
labelled according to which two emotions have been mixed. For instance, the top row illustrates the
five degrees by which happiness (H) and sadness (S) have been blended. As with the Ekman 60 Faces
test, six emotions were involved: anger (A); disgust (D), fear (F), happiness (H), sadness (S), and
surprise (U).
Although all images illustrated were used as materials in the Emotion Hexagon Test, responses to those




1. BAFQ self-report and Ekman 60 Faces
2. BAFQ self-report and Emotion Hexagon
3. BAFQ informant-report and Ekman 60 Faces
4. BAFQ informant report and Emotion Hexagon
Correlation Matrix (3): BAFQ informant-report (emotionality, impulsivity,
aggression, social monitoring, and empathy) and Ekman 60 Faces (anger, disgust,











Emotionality Impulsivity Aggression Social
Monitoring
Empathy
60 Faces - r -.191 .189 .196 .045 .181
Anger
Sig. (2- .382 .390 .370 .840 .410
tailed)
60 Faces - r -.320 -.304 -.618 -.435 -.389
Disgust
Sig. en¬ .138 .160 .002** .038* .066
tailed)
60 Faces - r -.345 -.210 -.069 -.245 -.047
Fear
Sig. (2- .108 .336 .756 .260 .830
tailed)
60 Faces - r .075 .151 .199 -.181 .006
Sadness
Sig. en¬ .734 .492 .362 .410 .980
tailed)
60 Faces - r -.304 -.087 -.106 -.370 -.112
Total Score
Sig. en¬ .158 .692 .632 .082 .610
tailed)
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).
Correlation Matrix (4): BAFQ informant-report (emotionality, impulsivity,
aggression, social monitoring, and empathy) and Ekman 60 Faces (anger, disgust,



















r -.215 -.224 -.617 -.331 -.204
Sig. en¬
tailed)
.326 .306 .002** .124 .352
Hexagon -
Total Score
r -.090 -.009 -.194 -.429 -.149
Sig. GZ-
tailed)
.684 .968 .376 .042* .500
** Correlation is significant at the 0.01 level (1-tailed).
* Correlation is significant at the 0.05 level (1-tailed).
Correlation Matrix (1): BAFQ self-report (emotionality, impulsivity, aggression,
social monitoring, and empathy) and Ekman 60 Faces (anger, disgust, fear, sadness
and total score); N = 24











60 Faces - r -.149 -.018 .083 .217 .231
Anger
Sig. (2- .486 .934 .702 .308 .278
tailed)
60 Faces - r -.110 -.401 .188 -.140 -.192
Disgust
Sig. (2- .610 .052 .380 .514 .370
tailed)
60 Faces - r -.375 -.177 -.141 .082 .081
Fear
Sig. (2- .072 .408 .512 .702 .706
tailed)
60 Faces - r -.210 -.112 .048 .135 .127
Sadness
Sig. (2- .324 .602 .824 .530 .556
tailed)
60 Faces - r -.392 -.304 -.016 .043 .072
Total Score
Sig. (2- .058 .148 .942 .840 .738
tailed)
* Correlation is significant at the 0.05 level (1-tailed).
** Correlation is significant at the 0.01 level (1-tailed).
Correlation Matrix (2): BAFQ self-report (emotionality, impulsivity, aggression,



















r .049 -.413 .214 -.067 -.120
Sig. (2-
tailed)
.820 .046* .316 .756 .578
Hexagon -
Total Score
r -.274 -.424 .027 -.019 -.091
Sig. (2-
tailed)
.196 .040* .900 .930 .674
** Correlation is significant at the 0.01 level (1 -tailed).
* Correlation is significant at the 0.05 level (1-tailed).
